0001644488 true FY No No Yes Yes P1Y 0001644488 2021-04-01 2022-03-31 0001644488 2021-10-31 0001644488 2022-06-10 0001644488 2022-03-31 0001644488 2021-03-31 0001644488 us-gaap:SeriesAPreferredStockMember 2022-03-31 0001644488 us-gaap:SeriesAPreferredStockMember 2021-03-31 0001644488 us-gaap:SeriesBPreferredStockMember 2022-03-31 0001644488 us-gaap:SeriesBPreferredStockMember 2021-03-31 0001644488 us-gaap:SeriesCPreferredStockMember 2022-03-31 0001644488 us-gaap:SeriesCPreferredStockMember 2021-03-31 0001644488 us-gaap:CommonClassAMember 2022-03-31 0001644488 us-gaap:CommonClassAMember 2021-03-31 0001644488 us-gaap:CommonClassBMember 2022-03-31 0001644488 us-gaap:CommonClassBMember 2021-03-31 0001644488 SHRV:SeriesAConvertiblePreferredStockMember 2022-03-31 0001644488 SHRV:SeriesAConvertiblePreferredStockMember 2021-03-31 0001644488 SHRV:SeriesBConvertiblePreferredStockMember 2022-03-31 0001644488 SHRV:SeriesBConvertiblePreferredStockMember 2021-03-31 0001644488 SHRV:SeriesCConvertiblePreferredStockMember 2022-03-31 0001644488 SHRV:SeriesCConvertiblePreferredStockMember 2021-03-31 0001644488 2020-04-01 2021-03-31 0001644488 2020-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-03-31 0001644488 us-gaap:CommonStockMember 2020-03-31 0001644488 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001644488 SHRV:SubscriptionReceivableMember 2020-03-31 0001644488 SHRV:SharesToBeIssuedMember 2020-03-31 0001644488 us-gaap:TreasuryStockMember 2020-03-31 0001644488 us-gaap:RetainedEarningsMember 2020-03-31 0001644488 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-03-31 0001644488 us-gaap:CommonStockMember 2021-03-31 0001644488 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001644488 SHRV:SubscriptionReceivableMember 2021-03-31 0001644488 SHRV:SharesToBeIssuedMember 2021-03-31 0001644488 us-gaap:TreasuryStockMember 2021-03-31 0001644488 us-gaap:RetainedEarningsMember 2021-03-31 0001644488 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2021-03-31 0001644488 SHRV:SubscriptionReceivableMember 2020-04-01 2021-03-31 0001644488 SHRV:SharesToBeIssuedMember 2020-04-01 2021-03-31 0001644488 us-gaap:TreasuryStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:RetainedEarningsMember 2020-04-01 2021-03-31 0001644488 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-04-01 2021-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:CommonStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:AdditionalPaidInCapitalMember 2021-04-01 2022-03-31 0001644488 SHRV:SubscriptionReceivableMember 2021-04-01 2022-03-31 0001644488 SHRV:SharesToBeIssuedMember 2021-04-01 2022-03-31 0001644488 us-gaap:TreasuryStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:RetainedEarningsMember 2021-04-01 2022-03-31 0001644488 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-04-01 2022-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesAPreferredStockMember 2022-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesBPreferredStockMember 2022-03-31 0001644488 us-gaap:PreferredStockMember us-gaap:SeriesCPreferredStockMember 2022-03-31 0001644488 us-gaap:CommonStockMember 2022-03-31 0001644488 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001644488 SHRV:SubscriptionReceivableMember 2022-03-31 0001644488 SHRV:SharesToBeIssuedMember 2022-03-31 0001644488 us-gaap:TreasuryStockMember 2022-03-31 0001644488 us-gaap:RetainedEarningsMember 2022-03-31 0001644488 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001644488 srt:ProFormaMember 2021-04-01 2022-03-31 0001644488 srt:ProFormaMember 2020-04-01 2021-03-31 0001644488 SHRV:OneMerchantProcessorMember 2022-03-31 0001644488 SHRV:OneMerchantProcessorMember 2021-03-31 0001644488 us-gaap:BuildingImprovementsMember 2021-04-01 2022-03-31 0001644488 us-gaap:FurnitureAndFixturesMember 2021-04-01 2022-03-31 0001644488 us-gaap:OfficeEquipmentMember 2021-04-01 2022-03-31 0001644488 us-gaap:ComputerEquipmentMember 2021-04-01 2022-03-31 0001644488 us-gaap:SoftwareDevelopmentMember 2021-04-01 2022-03-31 0001644488 us-gaap:LeaseholdImprovementsMember 2021-04-01 2022-03-31 0001644488 SHRV:ServicesOfferedOnSubscriptionBasisMember 2022-03-31 0001644488 SHRV:ServicesOfferedOnSubscriptionBasisMember 2021-03-31 0001644488 SHRV:CustomersRightOfReturnMember 2022-03-31 0001644488 SHRV:CustomersRightOfReturnMember 2021-03-31 0001644488 SHRV:CustomerLoyaltyPointsMember 2022-03-31 0001644488 SHRV:CustomerLoyaltyPointsMember 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomersMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:RecurringCustomersMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:NewCustomerMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:IndependentDistributorsMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomersMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:RecurringCustomersMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:NewCustomersMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:IndependentDistributorsMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomersAndIndependentDistributorsMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomersAndIndependentDistributorsMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:NutraceuticalProductsMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:CoffeeAndCoffeeRelatedProductsMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:WeightManagementProductsMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:OtherHealthAndWellnessProductsMember us-gaap:CustomerConcentrationRiskMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:ProductConcentrationRiskMember SHRV:HealthAndWellnessProductsMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:NutraceuticalProductsMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:CoffeeAndCoffeeRelatedProductsMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember SHRV:HealthAndWellnessMember us-gaap:CustomerConcentrationRiskMember 2020-04-01 2021-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomerMember 2021-04-01 2022-03-31 0001644488 us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember SHRV:CustomerMember 2020-04-01 2021-03-31 0001644488 SHRV:PurchasesMember us-gaap:SupplierConcentrationRiskMember SHRV:ThirdPartyMember 2021-04-01 2022-03-31 0001644488 SHRV:PurchasesMember us-gaap:SupplierConcentrationRiskMember SHRV:ThirdPartyMember 2020-04-01 2021-03-31 0001644488 SHRV:PurchasesMember us-gaap:SupplierConcentrationRiskMember SHRV:ThirdPartyMember SHRV:SouthKoreanMember 2021-04-01 2022-03-31 0001644488 srt:MinimumMember SHRV:InvestmentMember 2022-03-31 0001644488 srt:MaximumMember SHRV:InvestmentMember 2022-03-31 0001644488 SHRV:InvestmentMember 2022-03-31 0001644488 currency:KRW 2022-03-31 0001644488 us-gaap:FairValueInputsLevel3Member 2022-03-31 0001644488 us-gaap:FairValueInputsLevel1Member 2022-03-31 0001644488 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001644488 us-gaap:FairValueInputsLevel1Member 2021-03-31 0001644488 us-gaap:FairValueInputsLevel2Member 2021-03-31 0001644488 us-gaap:FairValueInputsLevel3Member 2021-03-31 0001644488 SHRV:ConvertibleNotesMember 2022-03-31 0001644488 SHRV:ConvertibleNotesMember 2021-03-31 0001644488 SHRV:ConvertibleNotesMember 2021-04-01 2022-03-31 0001644488 SHRV:ConvertibleNotesMember 2020-04-01 2021-03-31 0001644488 SHRV:StockWarrantsMember 2021-04-01 2022-03-31 0001644488 SHRV:StockWarrantsMember 2020-04-01 2021-03-31 0001644488 us-gaap:ConvertiblePreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:ConvertiblePreferredStockMember 2020-04-01 2021-03-31 0001644488 SHRV:OneThousandFortyFourProLlcMember 2021-01-31 0001644488 SHRV:OneThousandFortyFourProLlcMember 2021-01-01 2021-01-31 0001644488 SHRV:LoanAgreementMember SHRV:OneThousandFortyFourProLlcMember 2022-01-26 0001644488 SHRV:MojiLifeLLCMember 2022-01-14 0001644488 SHRV:MojiLifeMember 2022-01-01 2022-01-14 0001644488 SHRV:OneThousandFortyFourProLlcMember 2022-03-31 0001644488 SHRV:OneThousandFortyFourProLlcMember 2021-03-31 0001644488 SHRV:MojiLifeLLCMember 2022-03-31 0001644488 SHRV:MojiLifeLLCMember 2021-03-31 0001644488 SHRV:OtherMember 2022-03-31 0001644488 SHRV:OtherMember 2021-03-31 0001644488 SHRV:SouthKoreanSubsidiaryMember 2022-03-31 0001644488 us-gaap:BuildingMember 2021-12-01 2021-12-31 0001644488 2021-12-31 0001644488 us-gaap:BuildingMember 2021-12-30 2021-12-31 0001644488 srt:OfficeBuildingMember 2022-03-31 0001644488 us-gaap:SubsequentEventMember SHRV:LoanAgreementMember SHRV:AmericanPacificBancorpIncMember 2022-06-15 0001644488 us-gaap:SoftwareDevelopmentMember 2021-03-31 0001644488 us-gaap:LeaseholdImprovementsMember 2020-04-01 2021-03-31 0001644488 SHRV:StemtechCorporationMember SHRV:SecuritiesPurchaseAgreementMember 2021-09-30 0001644488 SHRV:GlobeNetWirelessCorpMember SHRV:SecurityPurchaseAgreementMember 2021-09-30 0001644488 SHRV:ConvertibleNotesMember SHRV:SecurityPurchaseAgreementMember 2021-09-01 2021-09-30 0001644488 SHRV:SecurityPurchaseAgreementMember SHRV:ConvertibleNotesMember 2021-09-19 0001644488 SHRV:GlobeNetWirelessCorpMember 2021-09-30 0001644488 SHRV:GlobeNetWirelessCorpMember 2021-09-01 2021-09-30 0001644488 SHRV:MembershipUnitPurchaseAgreementMember SHRV:MojiLifeLLCMember 2021-09-30 0001644488 SHRV:MojiLifeLLCMember 2021-09-01 2021-09-30 0001644488 SHRV:GNTWStockWarrantMember 2022-03-31 0001644488 SHRV:GNTWStockWarrantMember 2021-03-31 0001644488 SHRV:GNTWCommonStockMember 2022-03-31 0001644488 SHRV:GNTWCommonStockMember 2021-03-31 0001644488 SHRV:StemtechConvertibleNoteMember 2022-03-31 0001644488 SHRV:StemtechConvertibleNoteMember 2021-03-31 0001644488 SHRV:MojiLifeLLCMember 2022-03-31 0001644488 SHRV:MojiLifeLLCMember 2021-03-31 0001644488 SHRV:CommercialBankMember SHRV:PaycheckProtectionProgramMember 2020-05-01 2020-05-31 0001644488 SHRV:MaturityOneMember 2021-04-01 2022-03-31 0001644488 SHRV:MaturityOneMember 2020-04-01 2021-03-31 0001644488 SHRV:MaturityOneMember 2022-03-31 0001644488 SHRV:MaturityOneMember 2021-03-31 0001644488 SHRV:MaturityTwoMember 2021-04-01 2022-03-31 0001644488 SHRV:MaturityTwoMember 2020-04-01 2021-03-31 0001644488 SHRV:MaturityTwoMember 2022-03-31 0001644488 SHRV:MaturityTwoMember 2021-03-31 0001644488 SHRV:MaturityThreeMember 2021-04-01 2022-03-31 0001644488 SHRV:MaturityThreeMember 2020-04-01 2021-03-31 0001644488 SHRV:MaturityThreeMember 2022-03-31 0001644488 SHRV:MaturityThreeMember 2021-03-31 0001644488 SHRV:ConvertibleNotesMember SHRV:HWHInternationalIncMember 2017-10-31 0001644488 SHRV:ConvertibleNotesMember SHRV:HWHInternationalIncMember 2017-10-01 2017-10-31 0001644488 SHRV:HWHInternationalIncMember 2017-10-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember SHRV:SecurityPurchaseAgreementMember 2021-04-30 0001644488 SHRV:SecurityPurchaseAgreementMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-01 2021-04-30 0001644488 SHRV:SecurityPurchaseAgreementMember SHRV:DecentralizedSharingSystemsIncMember us-gaap:CommonClassAMember 2022-03-31 0001644488 SHRV:SecurityPurchaseAgreementMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-01 2022-03-31 0001644488 SHRV:ConvertibleNotesMember 2021-04-01 2022-03-31 0001644488 SHRV:ConvertibleNotesMember 2020-04-01 2021-03-31 0001644488 srt:MinimumMember 2022-03-31 0001644488 srt:MaximumMember 2022-03-31 0001644488 us-gaap:GeneralAndAdministrativeExpenseMember 2021-04-01 2022-03-31 0001644488 us-gaap:GeneralAndAdministrativeExpenseMember 2020-04-01 2021-03-31 0001644488 SHRV:DepreciationAndAmortizationMember 2021-04-01 2022-03-31 0001644488 SHRV:DepreciationAndAmortizationMember 2020-04-01 2021-03-31 0001644488 us-gaap:InterestExpenseMember 2021-04-01 2022-03-31 0001644488 us-gaap:InterestExpenseMember 2020-04-01 2021-03-31 0001644488 SHRV:ForeignStartupOperationMember 2021-04-01 2022-03-31 0001644488 SHRV:ForeignStartupOperationMember 2020-04-01 2021-03-31 0001644488 SHRV:ForeignStartupOperationMember 2022-03-31 0001644488 SHRV:ForeignStartupOperationMember 2021-03-31 0001644488 2020-02-29 0001644488 2022-04-01 0001644488 2021-04-01 0001644488 country:US srt:MinimumMember 2021-04-01 2022-03-31 0001644488 country:US srt:MaximumMember 2021-04-01 2022-03-31 0001644488 country:KR 2021-04-01 2022-03-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:MrChanMember 2020-07-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:MrChanMember us-gaap:CommonClassAMember 2020-07-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember us-gaap:CommonClassAMember SHRV:MrChanMember 2020-07-01 2020-07-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember 2021-04-05 0001644488 us-gaap:WarrantMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-04 2021-04-05 0001644488 us-gaap:WarrantMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-05 0001644488 us-gaap:CommonClassAMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-30 0001644488 SHRV:DecentralizedSharingSystemsIncMember 2021-04-04 2021-04-05 0001644488 2021-04-04 2021-04-05 0001644488 us-gaap:CommonClassAMember 2021-04-30 0001644488 SHRV:SecurityPurchaseAgreementMember SHRV:DecentralizedSharingSystemsIncMember 2021-04-04 2021-04-05 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:MrChanMember 2021-12-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember 2021-12-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember us-gaap:CommonClassAMember 2021-12-31 0001644488 us-gaap:WarrantMember SHRV:DecentralizedSharingSystemsIncMember 2021-12-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember SHRV:StockPurchaseAndShareSubscriptionAgreementMember 2021-12-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember SHRV:StockPurchaseAndShareSubscriptionAgreementMember 2021-12-01 2021-12-31 0001644488 SHRV:BusinessConsultingAgreementMember 2022-01-31 0001644488 SHRV:ConsultingAgreementMember 2022-01-31 0001644488 SHRV:ConsultingAgreementMember 2022-01-01 2022-01-31 0001644488 SHRV:ConsultingAgreementMember 2022-01-01 2022-03-31 0001644488 SHRV:BusinessConsultingAgreementMember us-gaap:CommonClassAMember 2022-01-01 2022-01-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember SHRV:ClassACommonStockMember 2022-03-01 2022-03-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember 2022-03-01 2022-03-31 0001644488 SHRV:AlsetTitleMember 2021-12-01 2021-12-31 0001644488 SHRV:HWHInternationalIncMember 2017-10-01 2017-10-31 0001644488 SHRV:HWHWorldIncMember 2022-03-31 0001644488 SHRV:HWHWorldIncMember 2021-04-01 2022-03-31 0001644488 SHRV:AdvisoryAgreementMember SHRV:HWHWorldIncMember 2021-09-01 2021-09-30 0001644488 SHRV:AdvisoryAgreementMember SHRV:HWHWorldIncMember 2021-04-01 2022-03-31 0001644488 SHRV:ImpactBiomedicalIncMember 2021-04-01 2022-03-31 0001644488 SHRV:KBeautyResearchLabCoLtdMember 2022-03-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember 2021-04-01 2022-03-31 0001644488 SHRV:AlchemistHoldingLLCMember 2020-02-01 2020-02-29 0001644488 SHRV:AlchemistHoldingLLCMember SHRV:RelatedPartyLeglClaimsMember 2020-02-01 2020-02-29 0001644488 SHRV:AlchemistHoldingsLLCMember 2020-06-30 0001644488 SHRV:AlchemistHoldingsLLCMember 2022-03-31 0001644488 SHRV:SubLeaseAgreementMember SHRV:AlchemistHoldingsLLCMember 2022-03-31 0001644488 SHRV:SubLeaseAgreementMember 2021-04-01 2022-03-31 0001644488 SHRV:DecentralizedSharingSystemsIncMember 2020-04-01 2021-03-31 0001644488 SHRV:BusinessConsultingAgreementMember SHRV:AmericanPremimumWaterCorporationMember 2021-07-01 2021-07-31 0001644488 us-gaap:PreferredStockMember 2022-03-31 0001644488 SHRV:SeriesAConvertiblePreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:SeriesAPreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:SeriesCPreferredStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:SeriesCPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonClassAMember srt:MaximumMember 2022-03-31 0001644488 us-gaap:CommonClassBMember srt:MaximumMember 2022-03-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:ClassACommonStockMember 2020-07-01 2020-07-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:ClassACommonStockMember 2020-07-31 0001644488 us-gaap:CommonStockMember 2020-07-31 0001644488 2020-07-01 2020-07-31 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:ClassACommonStockMember 2021-04-01 2021-04-30 0001644488 2021-04-30 0001644488 2021-04-01 2021-04-30 0001644488 us-gaap:CommonStockMember 2021-04-30 0001644488 SHRV:StockPurchaseAndShareSubscriptionAgreementMember SHRV:ClassACommonStockMember 2021-12-31 0001644488 us-gaap:CommonStockMember 2021-12-31 0001644488 2021-12-01 2021-12-31 0001644488 SHRV:BusinessConsultingAgreementMember 2022-01-30 0001644488 SHRV:BusinessConsultingAgreementMember 2022-02-28 0001644488 SHRV:ClassACommonStockMember SHRV:RobertOblonMember 2020-04-01 2021-03-31 0001644488 SHRV:ClassACommonStockMember SHRV:MultiPartySettlementAgreementMember 2020-04-01 2021-03-31 0001644488 SHRV:ClassACommonStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonClassAMember 2021-04-01 2022-03-31 0001644488 SHRV:ClassACommonStockMember 2021-04-01 2022-03-31 0001644488 us-gaap:SeriesBPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonClassBMember 2020-04-01 2021-03-31 0001644488 us-gaap:SeriesAPreferredStockMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonClassAMember 2020-04-01 2021-03-31 0001644488 us-gaap:CommonStockMember srt:MaximumMember 2021-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember 2020-04-01 2021-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember srt:MinimumMember 2021-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember srt:MaximumMember 2021-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember 2021-04-01 2022-03-31 0001644488 SHRV:DirectorsOfficersAndEmployeesMember 2021-04-01 2022-03-31 0001644488 SHRV:ConsultantsMember 2021-04-01 2022-03-31 0001644488 us-gaap:WarrantMember 2020-03-31 0001644488 us-gaap:WarrantMember 2020-04-01 2021-03-31 0001644488 us-gaap:WarrantMember 2021-03-31 0001644488 us-gaap:WarrantMember 2021-04-01 2022-03-31 0001644488 us-gaap:WarrantMember 2022-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember 2020-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember 2021-03-31 0001644488 SHRV:MembersOfIndependentSalesForceMember 2022-03-31 0001644488 SHRV:ConsultantsMember 2020-03-31 0001644488 SHRV:ConsultantsMember 2020-04-01 2021-03-31 0001644488 SHRV:ConsultantsMember 2021-03-31 0001644488 SHRV:ConsultantsMember 2022-03-31 0001644488 SHRV:WarrantOneMember 2022-03-31 0001644488 SHRV:WarrantOneMember 2021-04-01 2022-03-31 0001644488 SHRV:WarrantTwoMember 2022-03-31 0001644488 SHRV:WarrantTwoMember 2021-04-01 2022-03-31 0001644488 SHRV:WarrantThreeMember 2022-03-31 0001644488 SHRV:WarrantThreeMember 2021-04-01 2022-03-31 0001644488 SHRV:WarrantFourMember 2022-03-31 0001644488 SHRV:WarrantFourMember 2021-04-01 2022-03-31 0001644488 SHRV:WarrantFiveMember 2022-03-31 0001644488 SHRV:WarrantFiveMember 2021-04-01 2022-03-31 0001644488 SHRV:WarrantSixMember 2022-03-31 0001644488 SHRV:WarrantSixMember 2021-04-01 2022-03-31 0001644488 SHRV:AlchemistHoldingsLLCMember 2020-02-29 0001644488 SHRV:HealthAndWellnessProductsMember 2021-04-01 2022-03-31 0001644488 SHRV:HealthAndWellnessProductsMember 2020-04-01 2021-03-31 0001644488 SHRV:OtherMember 2021-04-01 2022-03-31 0001644488 SHRV:OtherMember 2020-04-01 2021-03-31 0001644488 SHRV:HealthAndWellnessMember 2022-03-31 0001644488 SHRV:HealthAndWellnessMember 2021-03-31 0001644488 us-gaap:CorporateMember 2022-03-31 0001644488 us-gaap:CorporateMember 2021-03-31 0001644488 us-gaap:CorporateMember 2021-04-01 2022-03-31 0001644488 us-gaap:CorporateMember 2020-04-01 2021-03-31 0001644488 country:US 2021-04-01 2022-03-31 0001644488 country:US 2020-04-01 2021-03-31 0001644488 country:CA 2021-04-01 2022-03-31 0001644488 country:CA 2020-04-01 2021-03-31 0001644488 country:KR 2021-04-01 2022-03-31 0001644488 country:KR 2020-04-01 2021-03-31 0001644488 SHRV:OtherMember 2021-04-01 2022-03-31 0001644488 SHRV:OtherMember 2020-04-01 2021-03-31 0001644488 country:US 2022-03-31 0001644488 country:US 2021-03-31 0001644488 country:KR 2022-03-31 0001644488 country:KR 2021-03-31 0001644488 SHRV:OtherMember 2022-03-31 0001644488 SHRV:OtherMember 2021-03-31 0001644488 us-gaap:SubsequentEventMember 2022-04-01 2022-04-30 0001644488 SHRV:AdvancingPromissoryNoteMember us-gaap:SubsequentEventMember 2022-05-31 0001644488 SHRV:AdvancingPromissoryNoteMember us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2022-05-31 0001644488 SHRV:AdvancingPromissoryNoteMember us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2022-05-01 2022-05-31 0001644488 us-gaap:SubsequentEventMember SHRV:ConvertiblePromissoryNoteMember 2022-05-31 0001644488 SHRV:ConvertiblePromissoryNoteMember us-gaap:SubsequentEventMember us-gaap:CommonClassAMember 2022-05-31 0001644488 us-gaap:SubsequentEventMember SHRV:LindenRealEstateHoldingsLLCMember 2022-05-31 0001644488 us-gaap:SubsequentEventMember SHRV:LindenRealEstateHoldingsLLCMember 2022-05-01 2022-05-31 0001644488 us-gaap:SubsequentEventMember SHRV:LindenRealEstateHoldingsLLCMember 2022-06-13 2022-06-15 0001644488 SHRV:CoFoundersAgreementMember 2020-02-29 0001644488 SHRV:CoFoundersAgreementMember 2022-03-31 0001644488 SHRV:CoFoundersAgreementMember us-gaap:SubsequentEventMember 2022-05-01 2022-05-31 0001644488 SHRV:CoFoundersAgreementMember us-gaap:SubsequentEventMember 2022-05-19 0001644488 SHRV:CoFoundersAgreementMember us-gaap:SubsequentEventMember 2022-04-01 2022-06-30 0001644488 us-gaap:SubsequentEventMember SHRV:FundingAgreementMember SHRV:MojiLifeMember 2022-05-01 2022-05-31 0001644488 us-gaap:SubsequentEventMember SHRV:FundingAgreementMember SHRV:MojiLifeMember 2022-05-31 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure iso4217:KRW

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 10-K/A

(Amendment 1)

 

 

 

ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the fiscal year ended MARCH 31, 2022
   
  -OR-
   
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
   
  For the transition period from ___________ to ___________
   
  Commission File No. 000-55997

 

SHARING SERVICES GLOBAL CORPORATION

(Exact name of registrant as specified in its charter)

 

Nevada   30-0869786
(State or other jurisdiction of incorporation or   (I.R.S. Employer Identification No.)
organization)    
     
1700 Coit Road, Suite 290, Plano, Texas   75075
(Address of principal executive offices)   (Zip Code)

 

 

Registrant’s telephone number, including area code: (469) 304-9400

 

Securities registered pursuant to Section 12(b) of the Act: None

 

Securities registered pursuant to Section 12(g) of the Act:

Common Stock, $0.0001 par value per share

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined under Rule 405 of the Securities Act. YES ☐ NO

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. YES ☐ NO

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. YES ☒ NO ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). YES ☒ NO ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐     Accelerated filer ☐
Non-accelerated filer     Smaller reporting company
      Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act.) YES ☐ NO

 

As of October 31, 2021, the aggregate market value of the registrant’s voting and non-voting Common Stock held by non-affiliates of the registrant, based on the closing price for the registrant’s Common Stock, was $4,370,560. As of June 10, 2022, there were 288,923,969 shares of the registrant’s Common Stock outstanding.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

Portions of the Proxy Statement related to the registrant’s 2022 Annual Meeting of Stockholders are incorporated into Part III of this Annual Report by reference where so indicated.

 

Auditor Firm ID   Auditor Name   Auditor Location
6121   Ankit Consulting Services, Inc.   Rancho Santa Margarita, California

 

 

 

 
 

 

EXPLANATORY NOTE

 

This Amendment No. 1 on Form 10-K/A to the Annual Report of Sharing Services Global Corporation (the “Company”) for the fiscal year ended March 31, 2022, filed with the Securities and Exchange Commission on June 21, 2022 (the “Original Form 10-K”), is being filed for the purpose of correcting a typographical error, as shown in the enclosed Consolidated Statements of Changes in Stockholders’ Equity for the Fiscal Years ended March 31, 2022 and 2021. As a result, the Company’s Consolidated Statements of Changes in Stockholders’ Equity for the Fiscal Years ended March 31, 2022 and 2021 is hereby amended and restated in its entirety.

 

Except as described above, this Form 10-K/A does not modify or update the disclosures in, or exhibits to, the Original Form 10-K, and such disclosures in, or exhibits to, the Original Form 10-K remain unchanged and speak as of the date of the filing of the Original Form 10-K, except that new certifications are being filed herewith. In particular, this Form 10-K/A does not modify the Company’s consolidated financial results for the periods presented in the Original Form 10-K.

 

ii
 

 

In March 2021, the Company changed its fiscal year-end from a fiscal year ending on April 30th to a fiscal year ending on March 31st. In this Annual Report, references to “the Company,” “Sharing Services,” “our company,” “we,” “our,” “ours” and “us” refer to Sharing Services Global Corporation (formerly Sharing Services, Inc.) and its consolidated subsidiaries unless otherwise indicated or the context otherwise requires.

 

cautionary notice regarding forward-looking statements

 

Statements in this Annual Report and in any documents incorporated by reference therein which are not purely historical, or which depend upon future events, may constitute forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Forward-looking statements generally contain words such as “anticipate,” “believe,” “estimate,” “expect,” “intend,” “plan,” “potential,” “project,” “target,” “can,” “could,” “may,” “should,” “will,” “will likely,” “would,” or the negative of such words and/or similar expressions. However, not all forward-looking statements contain these words.

 

Readers should not place undue reliance upon the Company’s forward-looking statements, since such statements speak only as of the date they were made. Such forward-looking statements may refer to events that ultimately do not occur, or may occur to a different extent, or occur at a different time than such forward-looking statements describe. Except to the extent required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements contained in this Annual Report and in any documents incorporated by reference therein, whether as a result of new information, future events, or otherwise. The Company acknowledges that all forward-looking statements involve risks and uncertainties that could cause actual events and/or results to differ materially from the events and/or results described in the forward-looking statements.

 

iii
 

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

 

Index to Consolidated Financial Statements

 

    Page
     
Report of Independent Registered Public Accounting Firm (PCAOB No. 6121)   2
     
Consolidated Balance Sheets as of March 31, 2022, and 2021   4
     
Consolidated Statements of Operations and Comprehensive Loss for the Fiscal Years ended March 31, 2022, and 2021   5
     
Consolidated Statements of Cash Flows for the Fiscal Years ended March 31, 2022, and 2021   6
     
Consolidated Statements of Changes in Stockholders’ Equity for the Fiscal Years ended March 31, 2022, and 2021   7
     
Notes to the Consolidated Financial Statements   8

 

1
 

 

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

To the Board of Directors and

Stockholders of Sharing Services Global Corporation

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheet of Sharing Services Global Corporation, formerly Sharing Services, Inc. (the “Company”) as of March 31, 2022 and 2021, and the related consolidated statements of operations and comprehensive loss, cash flows and changes in stockholders’ equity, for the each of the two fiscal years in the 23-month period ended March 31, 2022 and the related notes (collectively referred to as the consolidated financial statements). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of March 31, 2022 and 2021, and the results of its operations and its cash flows for each of the two fiscal years in the 23-month period ended March 31, 2022, in conformity with accounting principles generally accepted in the United States of America.

 

Basis for Opinion

 

These financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on the Company’s consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audit in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audits to obtain reasonable assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the consolidated financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the consolidated financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the consolidated financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the Board of Directors and that: (1) relate to accounts or disclosures that are material to the consolidated financial statements and (2) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Employee Stock Warrants

 

As described in Note 2 and Note 17 to the consolidated financial statements, the Company granted warrants to its employees and officers in connection with multi-year employment agreements which are exercisable at a variable exercise price.

 

The principal considerations for our determination that performing procedures relating to the valuation of employee stock warrants is a critical audit matter were (i) there was a high degree of auditor judgment and subjectivity in applying procedures relating to the fair value measurement of the warrants due to the significant amount of judgment by management when developing the estimate; (ii) significant audit effort was required in evaluating the significant assumptions relating to the estimates.

 

Our audit of the valuation of employee stock warrants included, but was not limited to, the following procedures:

 

  understanding of controls relating to stock warrants granted;
  examining original employment agreements;
  reviewing management’s assumptions used in the valuation and revaluation of the fair value;
  reviewing management’s criteria of allocation of expenses between compensatory expense and non-operating expense;
  reviewing the fair value computations of the warrants at each revaluation date;
  obtaining technical guidance from third party experts on the accounting treatment;
  evaluating the sufficiency of the Company’s disclosures relating to share- based payments.

 

2
 

 

Investment in Unconsolidated Entities

 

As described in Note 9 to the consolidated financial statements, the Company made investments in certain unconsolidated entities.

 

The principal considerations for our determination that performing procedures relating to the valuation of the investments is a critical audit matter were (i) there was a high degree of auditor judgment and subjectivity in applying procedures relating to the fair value measurement of the investments due to the significant amount of judgment by management when developing the estimate; (ii) significant audit effort was required in evaluating the significant assumptions relating to the estimates.

 

Our audit of the valuation of investment in unconsolidated entities included, but was not limited to, the following procedures:

 

  understanding of controls relating to investments made;
  examining original investment agreements;
  reviewing management’s assumptions used in the valuation and revaluation of the fair value of the investment;
  reviewing management’s criteria of allocation of fair value between components of investment;
  obtaining technical guidance from third party experts on the accounting treatment;
  reviewing management’s assumptions for impairment of investment;
  evaluating the valuation and presentation of the unrealized gain/loss on investments;
  evaluating the adequacy of the Company’s disclosures relating to investment in unconsolidated entities;

 

Related Party Convertible Note Payable

 

As described in Note 9 to the consolidated financial statements, the Company entered into a securities purchase agreement with a related party pursuant to which a convertible note was issued with detached warrants.

 

The principal considerations for our determination that performing procedures relating to the accounting treatment of the transaction is a critical audit matter were (i) there was a high degree of auditor judgment and subjectivity in applying procedures relating to the fair value measurement of the transaction due to the significant amount of judgment by management when developing the estimate; (ii) significant audit effort was required in evaluating the significant assumptions relating to the estimates.

 

Our audit of the valuation of the convertible notes payable and attached warrants included, but was not limited to, the following procedures:

 

  understanding of controls relating to the loan raised;
  examining original convertible note and warrants agreements;
  reviewing management’s assumptions used in the valuation of the note, warrants and related interest and fee;
  reviewing management’s criteria of allocation of fair value allocation between note and warrants;
  obtaining technical guidance from third party experts on the accounting treatment;
  reviewing management’s assumptions for accounting treatment of the whole transaction;
  evaluating the adequacy of the Company’s disclosures relating to the loan raised from related party;

 

Income Taxes

 

As described in Note 2 and Note 14 to the consolidated financial statements, the Company uses the asset and liability method in accounting for income taxes. The Company recognizes deferred tax assets and liabilities for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases (“temporary differences”).

 

The principal considerations for our determination that auditing income tax matters is a critical audit matter included the significant judgment made by management when considering factors in assessing the more-likely-than-not tax position. In turn, such management’s assessment led to challenging and subjective auditor judgment in performing our audit procedures.

 

Our audit of income tax matters included, but was not limited to, the following procedures:

 

  understanding of controls relating to management assessment of the tax positions;
  reviewing management’s tax computations, testing the completeness and accuracy of data used in computations;
  evaluating the appropriateness of the tax positions.

 

/s/ Ankit Consulting Services, Inc.

 

We have served as the Company’s auditor since September 2017.

Rancho Santa Margarita, California

June 20, 2022

 

3
 

 

SHARING SERVICES GLOBAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED BALANCE SHEETS

 

           
   As of March 31, 
   2022   2021 
ASSETS          
Current Assets          
Cash and cash equivalents  $17,023,266   $12,144,409 
Trade accounts receivable   1,682,958    1,514,359 
Income taxes receivable   300,000    1,011,740 
Notes receivable, net   -    94,600 
Inventory, net   4,374,236    2,471,310 
Other current assets, net   3,511,282    2,403,634 
Total Current Assets   26,891,742    19,640,052 
Property and equipment, net   9,585,141    887,950 
Right-of-use assets, net   593,389    428,075 
Deferred income taxes, net   

81,205

    1,873,170 
Investment in unconsolidated entities   5,063,940    - 
Intangible assets, net   688,670    188,567 
Other assets   260,637    219,142 
TOTAL ASSETS  $43,164,724   $23,236,956 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY          
Current Liabilities          
Accounts payable  $985,139   $1,295,174 
Accrued sales commission payable   3,745,481    4,713,777 
Employee stock warrants liability   452,050    3,132,161 
State and local taxes payable   1,339,366    1,048,717 
Note payable   -    1,040,400 
Accrued and other current liabilities   3,079,782    4,827,414 
Convertible notes payable, net of unamortized debt discount of $18,136,631 and unamortized deferred financing costs of $2,014,599 in 2022 and unamortized debt discount of $369 in 2021   9,898,770    99,631 
Total Current Liabilities   19,500,588    16,157,274 
Convertible notes payable, net of unamortized debt discount of $15,238 in 2021   -    34,762 
Settlement liability, long-term   373,677    808,071 
Lease liability, long-term   461,515    77,810 
TOTAL LIABILITIES   20,335,780    17,077,917 
Commitments and contingencies   -    - 
Stockholders’ Equity        
Preferred stock, $0.0001 par value, 200,000,000 shares authorized:          
Series A convertible preferred stock, $0.0001 par value, 100,000,000 shares designated, 3,100,000 shares and 5,100,000 shares issued and outstanding in 2022 and 2021, respectively   310    510 
Series B convertible preferred stock, $0.0001 par value, 10,000,000 shares designated, no shares issued and outstanding   -    - 
Series C convertible preferred stock, $0.0001 par value, 10,000,000 shares designated, 3,220,000 shares and 3,230,000 shares issued and outstanding in 2022 and 2021, respectively   322    323 
Common Stock, $0.0001 par value, 500,000,000 Class A shares authorized, 288,923,969 shares and 160,100,769 shares issued and outstanding in 2022 and 2021, respectively   28,892    16,010 
Common Stock, $0.0001 par value, 10,000,000 Class B shares authorized, no shares issued and outstanding   -    - 
Additional paid in capital   80,738,719    43,757,768 
Shares to be issued   12,146    12,146 
Accumulated deficit   (57,886,336)   (37,627,718)
Accumulated other comprehensive loss   (65,109)   - 
Total Stockholders’ Equity   22,828,944    6,159,039 
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY  $43,164,724   $23,236,956 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

4
 

 

SHARING SERVICES GLOBAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS

 

           
     
   For the Fiscal Years Ended March 31, 
   2022   2021 
Net sales  $34,424,314   $64,811,151 
Cost of goods sold   10,801,871    18,264,494 
Gross profit   23,622,443    46,546,657 
Operating expenses          
Selling and marketing expenses   17,239,655    29,740,974 
General and administrative expenses   19,714,963    18,983,209 
Total operating expenses   36,954,618    48,724,183 
Operating loss   (13,332,175)   (2,177,526)
Other income (expense)          
Interest expense, net   (12,204,444)   (47,613)
Gain on employee warrants liability   2,511,350    530,335 
Gain on extinguishment of debt   1,040,400    - 
Impairment loss on assets   (1,610,523)   - 
Unrealized gain on investments   3,663,940    - 
Other non-operating expense   (211,035)   (134,726)
Total other income (expense), net   (6,810,312)   347,996 
Loss before income taxes   (20,142,487)   (1,829,530)
Income tax benefit   (3,035,990)   (594,509)
Net loss  $(17,106,497)  $(1,235,021)
Other comprehensive loss (net of tax):          
Currency translation adjustments   (65,109)   - 
Total other comprehensive loss   (65,109)   - 
Comprehensive loss  $(17,171,606)  $(1,235,021)
Loss per share:          
Basic and diluted  $(0.08)  $(0.01)
Weighted average shares:          
Basic and diluted   206,211,711    172,046,517 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

5
 

 

SHARING SERVICES GLOBAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

           
   For the Fiscal Years Ended March 31, 
   2022   2021 
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(17,106,497)  $(1,235,021)
Adjustments to reconcile net loss to net cash used in operating activities:          
Depreciation and amortization   655,267    163,248 
Stock-based compensation   (2,120,111)   3,578,707 
Deferred income taxes   (1,038,359)   (536,862)
Amortization of debt discount and other   12,231,501    18,647 
Gain on extinguishment of debt   (1,040,400)   - 
Impairment loss on assets   2,331,554    - 
(Gain) loss on investments and other assets   (3,663,940)   114,599 
Non-cash consulting expense   

632,877

    - 
Provision for inventory obsolescence   635,137    1,095,068 
Changes in operating assets and liabilities:          
Accounts receivable   (163,599)   2,562,491 
Inventory   (2,579,581)   1,235,523 
Other current assets   1,098,003    (1,348,655)
Security deposits   (459)   (20,967)
Accounts payable   (304,637)   524,124 
Income taxes payable   (2,110,592)   (714,692)
Lease liability   (19,073)   2,617 
Accrued and other liabilities   (2,663,745)   (7,005,797)
Net Cash Used in Operating Activities   (15,226,654)   (1,566,970)
CASH FLOWS FROM INVESTING ACTIVITIES:          
Payments for property and equipment   (9,331,967)   (914,336)
Payments for intangible assets   -    (190,151)
Payments for notes receivable   (579,790)   (204,879)
Collections of notes receivable   5,000    113,727 
Payment for acquisition of nonconsolidated interests   (2,937,000)    - 
Net Cash Used in Investing Activities   (12,843,757)   (1,195,639)
CASH FLOWS FROM FINANCING ACTIVITIES:          
Proceeds from issuance of common stock   3,078,607    3,023,390 
Repayments of convertible notes payable   (100,000)   - 
Proceeds from convertible notes payable   30,000,000    - 
Proceeds from issuance of promissory notes payable   -    1,040,400 
Repurchase of common stock   -    (899,500)
Net Cash Provided by Financing Activities   32,978,607    3,164,290 
IMPACT OF CURRENCY RATE CHANGES ON CASH   (29,339)   - 
Increase in cash and cash equivalents   4,878,857    401,681 
Cash and cash equivalents, beginning of fiscal year   12,144,409    11,742,728 
Cash and cash equivalents, end of fiscal year  $17,023,266   $12,144,409 
           
Supplemental cash flow information          
Cash paid for interest  $52,541   $5,071 
Cash paid for income taxes  $47,489   $828,233 
Supplemented disclosure of non-cash investing and financing activities:          
Related party loan fees, consulting fees, and interest obligations settled with shares of common stock  $8,900,000   $- 
Investment origination fee collected in shares of investee stock  $500,000   $- 
Right-of-use assets obtained in exchange for operating lease liability  $523,998   $164,970 
Settlement obligation satisfied with shares of common stock  $-   $400,000 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

6
 

 

SHARING SERVICES GLOBAL CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

For the Fiscal Years Ended March 31,2022 and 2021

 

                                                                            
   Series A
Preferred Stock
   Series B
Preferred Stock
   Series C
Preferred Stock
   Common Stock                             
   Number of Shares   Par Value   Number of Shares   Par Value   Number of Shares   Par Value   Number of Shares   Par Value   Additional Paid In Capital   Subscription Receivable   Shares to be Issued   Treasury Stock   Accumulated Deficit   Accumulated Other Comprehensive Loss   Total 
Balance - April 30, 2020   32,478,750   $3,248    10,000,000   $1,000    3,490,000   $349    136,072,386   $13,607   $38,871,057   $(114,405)  $11,785   $(1,532,355)  $(33,992,697)  $-   $3,261,589 
Common stock issued for cash   -    -    -    -    -    -    30,000,000    3,000    5,397,000    -    -    -    (2,400,000)   -    3,000,000 
Common stock issued upon settlement of litigation   -    -    -    -    -    -    10,000,000    1,000    399,000    -    -    -    -    -    400,000 
Preferred stock retired   (5,628,750)   (563)   -    -    -    -    -    -    563    -    -    -    -    -    - 
Conversions of preferred stock   (21,750,000)   (2,175)   (10,000,000)   (1,000)   (260,000)   (26)   32,010,000    3,201    -    -    -    -    -    -    - 
Common stock redeemed upon settlement of stockholder litigation   -    -    -    -    -    -    (38,308,864)   (3,831)   (1,528,524)   -    -    1,532,355    -    -    - 
Repurchase and retirement of common stock   -    -    -    -    -    -    (17,500,000)   (1,750)   (897,750)   -    -    -    -    -    (899,500)
Stock-based compensation expense   -    -    -    -    -    -    -    -    2,201,004    -    -    -    -    -    2,201,004 
Proceeds from common stock warrants exercised   -    -    -    -    -    -    -    -    -    -    23,390    -    -    -    23,390 
Stock warrants exercised   -    -    -    -    -    -    7,827,247    783    (570,177)   -    (23,029)   -    -    -    (592,423)
Subscription receivable impaired   -    -    -    -    -    -    -    -    (114,405)   114,405    -    -    -    -    - 
Net loss   -    -    -    -    -    -    -    -    -    -    -    -    (1,235,021)   -    (1,235,021)
Balance – March 31, 2021   5,100,000   $510    -   $-    3,230,000   $323    160,100,769   $16,010   $43,757,768   $-   $12,146   $-   $(37,627,718)  $-   $6,159,039 
Common stock issued for cash   -    -    -    -    -    -    50,000,000    5,000    5,245,000    -    -    -    (2,250,000)   -    3,000,000 
Common stock issued for deferred financing costs and prepaid interest on debt   -    -    -    -    -    -    27,000,000    2,700    6,477,300    -    -    -    (1,080,000)   -    5,400,000 
Conversions or retirements of preferred stock   (2,000,000)   (200)   -    -    (10,000)   (1)   10,000    1    200    -    -    -    -    -    - 
Issuance of debt with beneficial conversion feature and in-the-money stock warrant, net of tax   -    -    -    -    -    -    -    -    21,330,000    -    -    -    -    -    21,330,000 
Expiration of common stock puts   -    -    -    -    -    -    -    -    -    -    -    -    177,879    -    177,879 
Stock-based compensation expense   -    -    -    -    -    -    -    -    3,780,000    -    -    -    -    -    3,780,000 
Stock warrants exercised   -    -    -    -    -    -    51,813,200    5,181    148,451    -    -    -    -    -    153,632 
Currency translation adjustments   -    -    -    -    -    -    -    -    -    -    -    -    -    (65,109)   (65,109)
Net loss   -    -    -    -    -    -    -    -    -    -    -    -    (17,106,497)   -    (17,106,497)
Balance – March 31, 2022   3,100,000   $310    -   $-    3,220,000   $322    288,923,969   $28,892   $80,738,719   $-   $12,146   $-   $(57,886,336)  $(65,109)  $22,828,944 

 

The accompanying notes are an integral part of these consolidated financial statements.

 

7
 

 

SHARING SERVICES GLOBAL CORPORATION AND SUBSIDIARIES

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION AND BUSINESS

 

Sharing Services Global Corporation (“Sharing Services”) and its subsidiaries (collectively, the “Company”) aim to build shareholder value by developing or investing in innovative emerging businesses and technologies that augment the Company’s products and services portfolio as described below, business competencies, and geographic reach. The Company was incorporated in the State of Nevada in April 2015.

 

In June 2021, the Company, through a subsidiary, commenced operations in the Republic of Korea (South Korea).

 

Health and Wellness Products - The Company’s subsidiaries operating in the health and wellness products industry, which accounted for approximately 99% of the Company’s consolidated net sales during the fiscal year 2022 and 2021, market our products primarily through an independent sales force, using a direct selling business model under the proprietary brand “The Happy Co.” Currently, The Happy Co. TM markets and distributes its health and wellness products primarily in the United States (the “U.S.”) and Canada. In June 2021, the Company, through a subsidiary, commenced operations in the Republic of Korea (South Korea).

 

Subscription-Based Travel Services - Through its subsidiary, Hapi Travel Destinations, the Company established a subscription-based travel services business under the proprietary brand “Hapi Travel” in May 2022. The Hapi Travel TM services are designed to offer the opportunity to travel to destinations in the U.S. and abroad to people of all ages, demographics, and economic backgrounds. Hapi Travel provides entrepreneurial opportunities to its subscribers by capitalizing on both the direct selling model and the retail travel business model.

 

Company-Owned and Franchised Destination Cafes – In August 2021, Sharing Services and Hapi Café, Inc, a company affiliated with Heng Fai Ambrose Chan, a Director of the Company, entered into a Master Franchise Agreement (the “MFA”) pursuant to which Sharing Services acquired the exclusive franchise rights in North America to the brand “Hapi Café.” Under the terms of the MFA, Sharing Services, directly or through its subsidiaries, has the right to operate no less than five (5) corporate-owned stores and can offer to the public sub-franchise rights to own and operate other stores, subject to the terms and conditions contained in the MFA.

 

Targeted Ownership Interests – Directly or through its subsidiaries, the Company from time to time will invest in emerging businesses, using a combination of debt and equity financing, in efforts to leverage the Company’s resources and business competencies and to participate in the growth of these businesses. As part of the Company’s commitment to the success of these emerging businesses, the Company, directly or through its subsidiaries, also plans to offer non-traditional inventory financing, equity or debt financing, order fulfillment and logistic, CRM “Back Office” solutions, and other success-critical services to these businesses.

 

Corporate Name Change

 

Sharing Services Global Corporation was originally incorporated under the name Sharing Services, Inc. In January 2019, Sharing Services, Inc. changed its corporate name to Sharing Services Global Corporation to better reflect the Company’s strategic intent to grow its business globally. In connection with the name change, the Company adopted the trading symbol SHRG effective April 4, 2019. Prior to this the Company’s Common Stock traded under the symbol SHRV.

 

Change of Fiscal Year

 

In March 2021, Sharing Services changed its fiscal year-end from a fiscal year ending on April 30th to a fiscal year ending on March 31st. Accordingly, the accompanying financial statements reflect the results of operations and cash flows for the fiscal year ended March 31, 2022 (12 months) compared to the eleven months ended March 31, 2021.

 

8
 

 

The following table sets forth certain information about the Company’s results of operations for the twelve (12) months ended March 31, 2022, and 2021. The information for the twelve (12) months ended March 31, 2021, represents unaudited pro-forma information.

 

           
   12 Months Ended March 31, 
   2022   2021 
Net sales  $34,424,314   $74,664,436 
Gross profit  $23,622,443   $53,630,538 
Loss from continuing operations  $(20,142,487)  $(1,988,501)
Loss before income taxes  $(20,142,487)  $(1,988,501)
Income tax benefit   (3,035,990)   (1,782,278)
Net loss  $(17,106,497)  $(206,223)
           
Basic and diluted loss per share  $(0.08)  $(0.00)

 

NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation

 

The accompanying consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and include the accounts of the Company and its consolidated subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

 

Reclassifications

 

Certain reclassifications have been made to the prior year’s data to conform with the current year’s presentation, primarily consisting of reclassification of the liability associated with uncertain tax positions of $904,643 as of March 31, 2021.

 

Use of Estimates and Assumptions

 

The preparation of financial statements in accordance with GAAP requires the use of judgment and requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent assets and liabilities, if any. Matters that require the use of estimates and assumptions include, among others: the recoverability of accounts receivable, the valuation of inventory, the useful lives of fixed assets, the assessment of long-lived assets for impairment, the nature and timing of satisfaction of multiple performance obligations resulting from contracts with customers, the allocation of the transaction price to multiple performance obligations in a sales transaction, the measurement and recognition of right-of-use assets and related lease liabilities, the valuation of share-based compensation awards, the provision for income taxes, the measurement and recognition of uncertain tax positions, and the valuation of loss contingencies, if any. Actual results may differ from these estimates in amounts that may be material to our consolidated financial statements. We believe that the estimates and assumptions used in the preparation of our consolidated financial statements are reasonable.

 

Cash and cash equivalents

 

The Company considers all highly liquid investments with original maturities of three months or less to be cash equivalents. Cash and cash equivalents include recent customer remittances deposited with our merchant processors at the balance sheet date, which generally settle within 24 to 72 hours. As of March 31, 2022, and 2021, cash and cash equivalents included cash held by our merchant processors of $3.3 million and $6.2 million, respectively, including $3.0 million and $4.9 million, respectively held by one merchant processor. In addition, as of March 31, 2022, and 2021, cash and cash equivalents held in bank accounts in foreign countries in the ordinary course of business were $1.4 million and $1.6 million, respectively. Amounts held by our merchant processor or held in bank accounts located in foreign countries are generally not insured by any federal agency.

 

9
 

 

Accounts Receivable and Allowance for Doubtful Accounts

 

As of March 31, 2022, and 2021, accounts receivable was $1.7 million and $1.5 million, which represents primarily amounts due from one merchant processor of approximately $1.5 million and $1.5 million, respectively. On a quarterly basis, the Company evaluates the collectability of its accounts receivable and reviews current economic trends and its historical collection data to determine the adequacy of its allowance for doubtful accounts, if any, based on its historical collection data and current information. An estimate for doubtful accounts is made when collection of the full amount is no longer probable. Account balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote. As of March 31, 2022, and 2021, the Company determined that no allowance was necessary.

 

Inventory and Cost of Goods Sold

 

Inventory consists of product held for sale in the normal course of our business. Inventory is stated at the lower of cost, determined using the first-in, first-out (“FIFO”) method, or net realizable value. Inventory cost reflects direct product costs and certain shipping and handling costs, such as in-bound freight. When estimating the net realizable value of inventory, we consider several factors including estimates of future demand for the product, historical turn-over rates, the age and sales history of the inventory, and historic and anticipated changes in our product offerings. See Note 6 – “INVENTORIES” below for more information.

 

Physical inventory counts are performed at all facilities on a quarterly basis. Between physical counts, management estimates inventory shrinkage based on the Company’s historical experience. The Company periodically assesses the realizability of its inventory based on evaluation of its inventory levels against historical and anticipated sales. During the fiscal year ended March 31, 2022, and 2021, the Company recognized a provision for inventory losses of $635,137 and $1.1 million, respectively, in connection with health and wellness products that were either damaged, expired, or slow-moving, based on the Company’s historical and anticipated sales. The Company reports its provisions for inventory losses in cost of goods sold in its consolidated statements of operations.

 

Cost of goods sold includes actual product costs, vendor rebates and allowances, if any, inventory shrinkage and certain shipping and handling costs, such as in-bound freight, associated with product sold. All other shipping and handling costs, including the cost to ship product to customers, are included in selling and marketing expenses in our consolidated statements of operations when incurred.

 

Property and Equipment

 

Property and equipment are recorded at cost and reported net of accumulated depreciation. Depreciation expense is recognized over an asset’s estimated useful life using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful lives of the assets or the term of the related lease, including lease renewals considered reasonably assured. The estimated useful lives of our property and equipment are as follows:

 

Buildings and building improvements– shorter of 39 years or remaining useful life of the asset
Furniture and fixtures – 3 years
Office equipment – 5 years
Computer Equipment – 3 years
Computer software – 3 years
Leasehold improvements – shorter of the remaining lease term or estimated useful live of the asset

 

The estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. The recoverability of long-lived assets is assessed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be fully recoverable, by comparing the net carrying amount of each asset to the total estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its undiscounted future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair value of the asset.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) Topic 606 when (or as) it transfers control of the promised goods and services to the customer in an amount that reflects the consideration the Company expects to be entitled to receive in exchange for those goods or services.

 

Revenue is recognized net of amounts due to taxing authorities (such as local and state sales tax). The Company’s customers place sales orders online and through the Company’s “back-office” operations, which creates a contract and establishes the transaction price. With respect to products sold, the Company’s performance obligation is satisfied upon receipt of the products by the customer. With respect to subscription-based revenue, including independent distributor membership fees, the Company’s performance obligation is satisfied over time (generally, up to one year). With respect to customer loyalty points awarded, the Company’s performance obligation is satisfied at the earliest of (a) the redemption or expiration date, or (b) when it is no longer probable the points will be redeemed. The Company assesses the probability an awards of customer loyalty points will be redeemed, based on its historic breakage rates. The timing of revenue recognition may differ from the time when the Company invoices the customer and/or collects payment. The Company has elected to treat shipping and handling costs as an activity to fulfill its performance obligations, rather than a separate performance obligation.

 

10
 

 

During the fiscal year ended March 31, 2022, a subsidiary of the Company introduced a Customer Loyalty Program which enables customers to earn points in a purchase transaction or through other means. The points are not redeemable for cash or product. Upon reaching 1,500 points, a customer may redeem the points and receive a $10 loyalty rewards card or certificate, that may be used when purchasing product. Points and loyalty rewards cards or certificates expire one year for the issuance date. However, points, loyalty rewards cards, and certificates are forfeited if the customer fails to remain active for a period of 90-days. The Company allocates a portion of the sales transaction price to each of its performance obligations therein, including points earned, and deferred revenue recognition until the earlier of (a) redemption or expiration of the rights conferred by the points or (b) the date when it is not probable the points will be redeemed (for example, because the holder is no longer an active customer).

 

As of March 31, 2022, and 2021, deferred revenue associated with product invoiced but not received by customers at the balance sheet date was $344,071 and $1.2 million, respectively; deferred revenue associated with unfulfilled performance obligations for services offered on a subscription basis was $70,968 and $153,216, respectively; deferred sales revenue associated with unfulfilled performance obligations for customers’ right of return was $63,890 and $95,780, respectively; and deferred sales revenue associated with customer loyalty points outstanding was $68,287 and $0, respectively. Deferred sales revenue is expected to be recognized over one year.

 

During the fiscal year ended March 31, 2022, and 2021, no individual customer, or related group of customers, represents 10% or more of our consolidated net sales. During the fiscal year ended March 31, 2022, approximately 66% of consolidated net sales were to consumers (including 32% to recurring customers, referred to herein as “SmartShip” sales, and approximately 34% to new customers) and approximately 34% of net sales were to independent distributors. During the fiscal year ended March 31, 2021, approximately 71% of our net sales were to consumers (including 43% to recurring customers, which we refer to as “SmartShip” sales, and approximately 28% to new customers) and approximately 29% of our net sales were to our independent distributors.

 

During the fiscal year ended March 31, 2022, and 2021, approximately 87% and 94%, respectively, of our consolidated net sales are to customers and independent distributors located in the U.S. (based on the customer’s shipping address). No other country represented more than 10% of total sales.

 

During the fiscal year ended March 31, 2022, substantially all the Company’s net sales are from health and wellness products (including approximately 33% from the sale of Nutraceutical products, approximately 32% from the sale of coffee and other functional beverages, approximately 11% from the sale of weight management products, and approximately 17% from the sale of all other health and wellness products). During the fiscal year ended March 31, 2021, approximately 99% of consolidated net sales are from our health and wellness products (including approximately 52% from the sale of Nutraceutical products, approximately 17% from the sale of coffee and coffee-related products, and approximately 30% from the sale of all other health and wellness products). During the fiscal year ended March 31, 2022, and 2021, our ten top selling products represent approximately 50% and 54%, respectively, of our consolidated net sales.

 

During the fiscal year ended March 31, 2022, and 2021, product purchases from one U.S.-based supplier accounted for approximately 64% and 99%, respectively, of total product purchases. In addition, during the fiscal year ended March 31, 2022, 33% of total product purchases were from one third-party supplier located in South Korea.

 

Sales Commissions

 

The Company recognizes sales commission expense when incurred. In the fiscal year ended March 31, 2022, and 2021, sales commission expense was approximately $16.3 million and $29.4 million, respectively, and is included in selling and marketing expenses in our consolidated statements of operations. The Company measures and recognizes sales commission expense based on the Company’s Distributor Compensation Plan. The Company’s independent distributors can earn commissions when they sell Company products to retail customers or to their downline independent distributors. Additionally, they can earn commissions when their personally sponsored distributors (or downline) sell products to end users. There is no limit as to the number of personally enrolled distributors or retail customers that an independent distributor may have and earned compensation for.

 

11
 

 

Share-Based Payments

 

The Company accounts for stock-based compensation awards to its directors, officers, and employees in accordance with ASC Topic 718, Compensation – Stock Compensation (“ASC 718”). During the fiscal year 2020, the Company, through a subsidiary, entered into multi-year employment agreements with certain employees. In general, each employment agreement contains (a) an Initial Warrant that vested immediately and is exercisable at a fixed exercise price and (b) Subsequent Warrants that vest over time and are exercisable at an exercise price calculated by multiplying a specified discount rate by the 10-day average stock price determined at the time of exercise. Generally, a Subsequent Warrants tranche vests in full at each anniversary of the employment agreement effective date, during the contractual term of employment. See Note 17 – “STOCK-BASED COMPENSATION” for more information.

 

As stated above, some stock warrants issued in connection with these multi-year employment agreements are exercisable at a variable exercise price, a price equal to the discounted 10-day average stock price determined at the time of exercise. In general, the Company begins recognizing the compensatory nature of the warrants at the service inception date and ceases recognition at the vesting date. Due to the variable nature of the exercise price for some grants, however, the Company remeasures compensation expense associated with these awards after the service period ends and until the warrant is exercised or expires. As such, the Company’s stock-based compensation expense contains components associated with (i) awards that have a fixed exercise price whose fair value is measured at the grant date and (ii) awards with a variable exercise price whose value is measured at the balance sheet date, including fully vested awards. The Company recognizes the income/expense component associated with the subsequent measure of fully vested awards as non-operating income/expense.

 

In the fiscal year ended March 31, 2022, income recognized in connection with stock-based compensation awards was $2.3 million, including (a) compensatory expense of $186,264 and (b) income associated with the subsequent measure of fully vested awards (see preceding paragraph) of $2.5 million. In the fiscal year ended March 31, 2021, expense recognized in connection with stock-based compensation awards was $3.0 million, including (a) compensatory expense of $3.6 million and (b) income associated with the subsequent measure of fully vested awards of $530,335.

 

Lease Accounting

 

The Company determines if an arrangement is a lease at inception. Determining whether a contract contains a lease includes judgment regarding whether the contract conveys the right to control the use of identified property or equipment for a period of time in exchange for consideration. The Company accounts for its lease obligations in accordance with ASC Topic 842, Leases, which requires lessees to, among other things, report on their balance sheets a right-of-use asset and a lease liability measured based on the present value of future lease payments over the term of the lease agreements for agreements classified as operating leases.

 

For all arrangements as a lessee, the Company has elected an accounting policy to combine non-lease components with the related-lease components and treat the combined items as a lease for accounting purposes. The Company measures lease related assets and liabilities based on the present value of lease payments, including in-substance fixed payments, variable payments that depend on an index or rate measured at the commencement date, and the amount the Company believes is probable the Company will pay the lessor under residual value guarantees when applicable. The Company discounts lease payments based on the Company’s estimated incremental borrowing rate at lease commencement (or modification), which is primarily based on the Company’s estimated credit rating, the lease term at commencement, and the contract currency of the lease arrangement. The Company has elected to exclude short term leases (leases with an original lease term less than one year) from the measurement of lease-related assets and liabilities.

 

The Company tests right-of-use assets in an operating or finance lease at the asset group level (because these assets are long-lived nonfinancial assets and should be accounted for the same way as other long-lived nonfinancial assets) whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable.

 

The Company leases space for its corporate headquarters, warehouse space, automobiles, and office and other equipment, under lease agreements classified as operating leases. See Note 13 – “LEASES” below for more information about the Company’s lease obligations.

 

Foreign Currency

 

During the fiscal year ended March 31, 2022, and 2021, approximately 87% and 94%, respectively, of our consolidated net sales are denominated in U.S. Dollars. During the fiscal year ended March 31, 2022, and 2021, sales denominated in no other currency accounted for 10% or more of net sales.

 

12
 

 

As part of its growth initiatives, the Company recently expanded operations outside the United States. The functional currency of each of our foreign operations is generally the respective local currency. Balance sheet accounts are translated into U.S. dollars (our reporting currency) at the rates of exchange in effect at the balance sheet date, while the results of operations and cash flows are generally translated using average exchange rates for the periods presented. Individually material transactions, if any, are translated using the actual rate of exchange on the transaction date. The resulting translation adjustments are recorded as a component of accumulated other comprehensive loss in our consolidated balance sheets.

 

In June 2021, the Company expanded its geographical footprint, and through its wholly owned subsidiary, commenced operations in the Republic of Korea (South Korea). The following exchange rates between the South Korean Won and the U.S. Dollar (“USD”) were used to translate the Company’s Korean operation’s financial statements:

 

   South Korean Won per USD 
Exchange rate as of March 31, 2022   1,212.99 
Average exchange rate for the fiscal year ended March 31, 2022   1,167.39 

 

Income Taxes

 

The Company uses the asset and liability method and follows ASC Topic 740 – Income Taxes (“ASC 740”) in accounting for its income taxes. The Company recognizes deferred tax assets and liabilities for the estimated future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases (“temporary differences”). Deferred tax assets and liabilities are measured using enacted tax rates expected to apply in the years in which temporary differences are anticipated to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rate is recognized in measuring results of operations in the period that includes the enactment date. Deferred tax assets are evaluated periodically, and a valuation allowance is recorded to reduce the carrying amounts of deferred tax assets to the amount expected to be realized unless it is more-likely-than-not that the assets will be realized in full. When assessing whether it is more-likely-than-not that the deferred tax assets will be realized, management considers multiple factors, including recent earnings history, expectations of future earnings, available carryforward periods, the availability of tax planning strategies, and other relevant quantitative and qualitative factors.

 

In determining the provision for income taxes, an annual effective income tax rate is used based on annual income, permanent differences between book and tax income, and statutory income tax rates. Accounting for income taxes involves judgment and the use of estimates.

 

The Company recognizes a liability for unrecognized tax benefits resulting from uncertain tax positions taken or expected to be taken in its tax returns, unless the weight of available evidence indicates it is more-likely-than-not that the tax position will be sustained on audit, including resolution through available appeals processes. We measure the tax position as the largest amount which is more-likely-than-not of being realized. The Company considers many factors when evaluating and estimating the Company’s tax positions, which may require periodic adjustments when new facts and circumstances become known. See Note 14 – “INCOME TAXES” for more information about the Company’s accounting for income taxes.

 

Investments

 

Investments in which the Company has the ability to exercise significant influence, but does not have a controlling interest, are accounted for using the equity method of accounting. Significant influence is generally considered to exist when the Company has voting shares representing 20% to 50%, and other factors, such as representation on the board of directors, voting rights and the impact of commercial arrangements, are considered in determining whether the equity method of accounting is appropriate. Under this method of accounting, the Company records its proportionate share of the net earnings or losses of equity method investments and a corresponding increase or decrease in the investment balances. Dividends received from equity method investments are recorded as reductions in the cost of such investments. The Company generally considers an ownership interest of 20% or higher to represent significant influence. The Company accounts for the investments in entities over which it has neither control nor significant influence, and no readily determinable fair value is available, using the investment’s cost minus any impairment, if necessary.

 

Investments are evaluated for impairment when facts or circumstances indicate that the fair value of a long-term investment is less than the carrying value. An impairment loss is recognized when a decline in fair value is determined to be other-than-temporary. The Company reviews several factors to determine whether a loss is other-than-temporary. These factors include, but are not limited to, the: (i) nature of the investment; (ii) cause and duration of the impairment; (iii) extent to which fair value is less than cost; (iv) financial condition and near-term prospects of the investment; and (v) ability to hold the security for a period of time sufficient to allow for any anticipated recovery in fair value.

 

13
 

 

Related Parties

 

A party is considered to be related to the Company if it, directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with the Company. Related parties also include principal owners of the Company, its management, members of the immediate families of principal owners of the Company and its management and other parties with which the Company may deal with if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its separate interests.

 

Comprehensive Income (Loss)

 

Comprehensive income (loss) is defined as the increase or decrease in stockholders’ equity during a period as a result of transactions and other events and circumstances, excluding transactions resulting from investments by owners and distributions to owners. For each of the fiscal years presented herein, the Company’s components of comprehensive loss included net loss and foreign currency translation adjustments, as reported in the consolidated statements of operations and comprehensive loss.

 

Segment Reporting

 

The Company follows ASC Topic 280, Segment Reporting. The Company’s management reviews the Company’s consolidated financial results when making decisions about allocating resources and assessing the performance of the Company as a whole and has determined that the Company’s reportable segments are: (a) the sale of health and wellness products, and (b) the sale of other products and services. See Note 19 – “BUSINESS SEGMENT AND GEOGRAPHIC AREA INFORMATION” for more information about the Company’s reportable segments.

 

Recently Issued Accounting Standard - Adopted

 

In December 2019, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes (“ASU 2019-12”). ASU 2019-12, among other things, (a) eliminates the exception to the incremental approach for intra-period tax allocation when there is a loss from continuing operations and income (or a gain) from other items, (b) eliminates the exception to the general methodology for calculating income taxes in an interim period when the year-to-date loss exceeds the anticipated loss for the year, (c) requires than an entity recognize a franchise tax (or a similar tax) that is partially based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax, and (d) requires than an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation for the interim period that includes the enactment date. For public companies, these amendments are effective for fiscal years, and interim periods within those fiscal years, that begin after December 15, 2020. The Company adopted the provisions of ASU 2019-12 effective April 1, 2021, and such adoption did not have a material impact on its consolidated financial statements.

 

Recently Issued Accounting Standard - Pending Adoption

 

In August 2020, the FASB issued ASU No. 2020-06, Debt – Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging – Contracts in Entity’s Own Equity (ASU 2020-06), which simplifies the accounting for certain convertible instruments. Among other things, under ASU 2020-06, the embedded conversion features no longer must be separated from the host contract for convertible instruments with conversion features not required to be accounted for as derivatives, or that do not result in substantial premiums accounted for as paid-in capital. ASU 2020-06 also eliminates the use of the treasury stock method when calculating the impact of convertible instruments on diluted Earnings per Share. For the Company, the provisions of ASU 2020-06 are effective for its fiscal quarter beginning on April 1, 2024. Early adoption is permitted, subject to certain limitations. The Company is evaluating the potential impact of adoption on its consolidated financial statements.

 

NOTE 3 – FAIR VALUE MEASUREMENTS

 

The Company’s financial instruments consist of cash equivalents, if any, accounts receivable, notes receivable, investments in unconsolidated entities, accounts payable, and notes payable, including convertible notes. The carrying amounts of cash equivalents, if any, accounts receivable, notes receivable, and accounts payable approximate their respective fair values due to the short-term nature of these financial instruments.

 

The Company’s measures and discloses the fair value of its financial instruments under the provisions of ASC Topic 820 – Fair Value Measurement, as amended (“ASC 820”). The Company defines “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e., the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level hierarchy for measuring fair value and requires entities to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. There were no transfers between the levels of the fair value hierarchy during the periods covered by the accompanying consolidated financial statements.

 

14
 

 

Consistent with the valuation hierarchy contained in ASC 820, we categorized certain of our financial assets and liabilities as follows:

 

   As of March 31, 2022 
   Total   Level 1   Level 2   Level 3 
Assets                    
Investment in unconsolidated entities  $5,063,940   $-   $-   $5,063,940 
Total assets  $5,063,940   $    $    $5,063,940 
Liabilities                    
Convertible notes payable  $5,840,000   $-   $5,790,000   $50,000 
Total liabilities  $5,840,000   $-   $5,790,000   $50,000 

 

   As of March 31, 2021 
   Total   Level 1   Level 2   Level 3 
Assets                    
Notes receivable  $94,600   $-   $-   $94,600 
Total assets  $94,600   $-   $-   $94,600 
Liabilities                    
Notes Payable  $1,040,400   $-   $-   $1,040,400 
Convertible notes payable   134,393    -    -    134,393 
Total liabilities  $1,174,793   $-   $-   $1,174,793 

 

Certain of the Company’s investments in unconsolidated entities are valued for purposes of this disclosure using unobservable inputs, since there are no observable market transactions for such investments. The fair value of notes receivable approximates the carrying value due to the short-term nature of the note. See Note 5 below for more information about our notes receivable.

 

As of March 31, 2022, convertible notes payable (including current maturities) are reported in our consolidated financial statements at amortized cost of $30.1 million, less unamortized debt discount and deferred financing costs, in the aggregate, of $20.2 million. As of March 31, 2021, convertible notes payable (including current maturities) are reported in our consolidated financial statements at amortized cost of $150,000, less unamortized debt discount of $15,607. Notes payable and certain convertible notes payable are valued for purposes of this disclosure using discounted cash flows and observable interest rates whenever available. See Notes 10 and 12 below for more information about our notes and convertible notes payable.

 

NOTE 4 – EARNINGS (LOSS) PER SHARE

 

The Company calculates basic earnings (loss) per share by dividing net earnings (loss) available to common shareholders by the weighted average number of common shares outstanding during the reporting period. Diluted earnings per share is calculated similarly but reflects the potential impact of shares issuable upon the conversion or exercise of our outstanding convertible Preferred Stock, convertible notes payable, stock warrants and other commitments to issue Common Stock, except where the impact would be anti-dilutive, as defined in GAAP.

 

The following table sets forth the computations of basic and diluted earnings (loss) per share for the periods indicated:

 

           
   Fiscal Year Ended March 31, 
   2022   2021 
Net loss  $(17,106,497)  $(1,235,021)
           
Weighted average basic and diluted shares   206,211,711    172,046,517 
Earnings (loss) per share:          
Basic and diluted  $(0.08)  $(0.01)

 

15
 

 

The following potentially dilutive securities and instruments were outstanding on the dates indicated, but excluded from the table above because their impact would be anti-dilutive:

 

           
   As of March 31, 
   2022   2021 
Convertible notes payable   158,403,141    10,406,100 
Stock warrants   68,475,290    34,128,212 
Convertible Preferred Stock   7,307,589    20,879,530 
Total potential incremental shares   234,186,020    65,413,842 

 

 

NOTE 5 – NOTES RECEIVABLE, NET

 

In January 2021, the Company, through a wholly owned subsidiary, and 1044PRO, LLC (“1044 PRO”) entered into a Funding Agreement pursuant to which the Company agreed to provide to 1044 PRO loans under a $250,000 revolving credit line. In December 2021, the parties to the Funding Agreement entered into a modification to the Funding Agreement pursuant to which the parties agreed to increase the amount of the revolving credit line to $310,000. Borrowings under the credit line, as amended, are payable in monthly installments in amounts determined in relation to the amount of each cash advance. In connection with the Funding Agreement, the Company acquired a 10% equity interest in 1044 PRO and a security interest in 1044 PRO’s cash receipts and in substantially all 1044 PRO’s assets.

 

On January 26, 2022, the parties to the Funding Agreement discussed in the preceding paragraph entered into a new Loan Agreement pursuant to which the Company agreed to loan to 1044Pro up to and additional $250,000, of which $125,000 was funded immediately. Borrowings under the Loan Agreement bear interest at 10%, are payable in full on or before July 26, 2023, and are secured by a security interest in substantially all 1044Pro’s assets and a security interest in 50% of 1044Pro’s members’ interest. Borrowings under the Loan Agreement are further secured by a personal guaranty executed by a member of 1044Pro.

 

On January 14, 2022, the Company and MojiLife, LLC (“MojiLife”), an unconsolidated subsidiary of the Company, entered into a loan agreement pursuant to which the Company agreed to provide to MojiLife a loan in the amount of $150,000. Borrowings are payable in equal monthly installment of $8,333 and are due in full on July 14, 2023.

 

On a quarterly basis, the Company evaluates the collectability of its notes receivable and reviews current economic trends and its historical collection data to determine the adequacy of its allowance for impairment losses based on its historical collection data and other relevant information. An estimate for impairment losses is recognized when collection of the full amount is no longer probable. Note balances are written off against the allowance after all means of collection have been exhausted and the potential for recovery is considered remote.

 

Notes receivable consist of the following:

 

   2022   2021 
   As of March 31, 
   2022   2021 
1044PRO, LLC  $436,520   $189,199 
MojiLife, LLC   150,000    - 
Other   15,000    20,000 
 Total   601,520    209,199 
Allowance for obsolescence   (601,520)   (114,599)
 Total Notes Receivable  $-   $94,600 

 

The following table reflects the activity in the allowance for impairment losses for the periods presented:

 SCHEDULE OF ALLOWANCE FOR IMPAIRMENT LOSSES

   2022   2021 
   Fiscal Year Ended March 31, 
   2022   2021 
Balance at beginning of fiscal year  $114,599   $- 
Provision for estimated impairment losses   491,921    114,599 
Write-offs and recoveries   (5,000)   - 
Balance at end of fiscal year  $601,520   $114,599 

 

16
 

 

NOTE 6 – INVENTORY, NET

 

Inventory consists of the following:

 

   2022   2021 
   As of March 31, 
   2022   2021 
Finished Goods  $4,482,291   $2,556,368 
Allowance for obsolescence   (108,055)   (85,058)
Inventory, net  $4,374,236   $2,471,310 

 

The increase in finished goods as of March 31, 2022, compared to as of March 31, 2021, reflects the inventory of the Company’s South Korean subsidiary (primarily skin care products) that started its operations in June 2021, of approximately $1.9 million.

 

The following table reflects the activity in the allowance for inventory obsolescence for the periods presented:

 

   2022   2021 
   Fiscal Year Ended March 31, 
   2022   2021 
Balance at beginning of fiscal year  $85,058   $- 
Provision for estimated obsolescence   635,137    1,095,068 
Write-offs and recoveries   (612,140)   (1,010,010)
Balance at end of fiscal year  $108,055   $85,058 

 

NOTE 7 – OTHER CURRENT ASSETS, NET

 

Other current assets consist of the following:

 

   2022   2021 
   As of March 31, 
   2022   2021 
Prepaid consulting fees  $2,867,123   $- 
Inventory-related deposits   

384,477

    

1,845,722

 
Employee advances   -    320,631 
Prepaid insurance and other operational expenses   201,275    210,665 

Deposits for sales events

   222,540    

-

 
Right to recover asset   15,632    26,616 

Subtotal

   3,691,047    2,403,634 

Less: allowance for losses

   (179,765)   - 
Other current assets  $3,511,282   $2,403,634 

 

Prepaid freight and other expenses consist of payments for goods and services (such as freight, trade show expenses and insurance premiums) which are expected to be realized in the next operating cycle. Right to recover asset is associated with our customers’ right of return and is expected to be realized in one year or less. As of March 31, 2022, and 2021, employee advances include $0 and $320,631, respectively, due from an employee in connection with payroll tax obligations associated with the exercise of compensatory stock warrants.

 

NOTE 8 – PROPERTY AND EQUIPMENT, NET

 

Property and equipment consist of the following:

SUMMARY OF PROPERTY AND EQUIPMENT

   2022   2021 
   As of March 31, 
   2022   2021 
Building and building improvements  $

8,976,878

   $- 
Computer software   875,925    734,510 
Furniture and fixtures   237,045    230,685 
Computer equipment   223,424    165,767 
Leasehold improvements and other   

263,208

    138,529 
Total property and equipment   10,576,480    1,269,491 
Impairment of property and equipment   (100,165)   - 
Accumulated depreciation and amortization   (891,174)   (381,541)
Property and equipment,net   $9,585,141   $887,950 

 

Depreciation and amortization expense for the fiscal year ended March 31, 2022, and 2021 was $534,371 and $161,663, respectively. During the fiscal year ended March 31, 2022, the Company recognized an impairment loss of $100,165 in connection with its formal plans to reorganize its Korean operations. See Note 20, “SUBSEQUENT EVENTS” for more details.

 

17
 

 

In December 2021, the Company, through as subsidiary, purchased an office building in Lindon, Utah for $8,942,640, including $3,675,000 allocated to land. The capitalized costs include legal and other professional fees incurred directly in connection with the purchase of the property. The Company assessed a useful life of the building (28 years). Depreciation and amortization expense for the fiscal year ended March 31, 2022, include $48,007 in connection with the building. On June 15, 2022, the Company and American Pacific Bancorp, Inc. (“APB”) entered a Loan Agreement pursuant to which APB loaned to the Company approximately $5.7 million. The loan is secured by a first mortgage interest on the Lindon, Utah building. See Note 20, “SUBSEQUENT EVENTS” for more details.

 

During the fiscal year ended March 31, 2021, the Company capitalized $715,354 in computer software in connection with upgrades to its information technology systems placed in service. In addition, during the fiscal year ended March 31, 2021, the Company incurred $163,106 in capitalizable costs primarily in connection with leasehold improvements for office facilities and ongoing upgrades to its information technology systems yet to be placed in service. These costs were reported in other assets in our consolidated balance sheets until the related assets were placed in service in 2022.

 

NOTE 9 – INVESTMENT IN UNCONSOLIDATED ENTITIES

 

In September 2021, the Company, Stemtech Corporation (“Stemtech”) and Globe Net Wireless Corp. (“GNTW”) entered into a Securities Purchase Agreement (the “SPA”) pursuant to which the Company invested $1.4 million in Stemtech in exchange for: (a) a Convertible Promissory Note in the amount of $1.4 million in favor of the Company (the “Convertible Note”) and (b) a detachable Warrant to purchase shares of GNTW common stock (the “GNTW Warrant”). Stemtech is a subsidiary of GNTW. As an inducement to enter into the SPA, GNTW agreed to pay to the Company an origination fee of $500,000, payable in shares of GNTW’s common stock. The Convertible Note matures on September 9, 2024, bears interest at the annual rate of 10%, and is convertible, at the option of the holder, into shares of GNTW’s common stock at a conversion rate calculated based on the closing price per share of GNTW’s common stock during the 30-day period ended September 19, 2021. The GNTW Warrant expires on September 13, 2024 and conveys the right to purchase up to 1.4 million shares of GNTW’s common stock at a purchase price calculated based on the closing price per share of GTNW’s common stock during the 10-day period ended September 13, 2021. In September 2021, GNTW issued to the Company 154,173 shares of its common stock, or less than 1% of the shares of GNTW then issued and outstanding, in payment of the origination fee.

 

The Company carries its investment in the Convertible Note, the GNTW Warrant and the shares of GNTW common stock at fair value in accordance with U.S. GAAP. During the fiscal year ended March 31, 2022, the Company recognized unrealized gains, before income tax, of $3.7 million in connection with its investment in the Convertible Note, the GNTW Warrant and the shares of GNTW common stock.

 

In September 2021, the Company entered into a Membership Unit Purchase Agreement pursuant to which the Company acquired a 30.75% equity interest in MojiLife, LLC, a limited liability company organized in the State of Utah, in exchange for $1,537,000. MojiLife is an emerging growth distributor of technology-based consumer products, such as cordless scent diffusers, for the home and the car, as well as proprietary home cleaning products and accessories.

 

Investment in unconsolidated entities consists of the following:

 

   2022   2021 
   As of March 31, 
   2022   2021 
Investment in detachable GNTW stock warrant  $3,570,000   $- 
Investment in GNTW common stock   393,141    - 
Investment in Stemtech convertible note   1,100,799    - 
Investment in MojiLife, LLC   1,537,000    - 
Subtotal   6,600,940    - 
Less, allowance for impairment losses   (1,537,000)   - 
Investments  $5,063,940   $- 

 

On a quarterly basis, the Company evaluates the recoverability of its investments and reviews current economic trends to determine the adequacy of its allowance for impairment losses based on each investee financial performance data and other relevant information. An estimate for impairment losses is recognized when recovery in fill of the Company’s investment is no longer probable. Investment balances are written off against the allowance after the potential for recovery is considered remote.

 

18
 

 

The following table reflects the activity in the allowance for impairment losses for the periods presented:

   2022   2021 
   Fiscal Year Ended March 31, 
   2022   2021 
Balance at beginning of fiscal year  $-   $- 
Provision for estimated impairment losses   1,537,000    - 
Balance at end of fiscal year  $1,537,000   $- 

 

NOTE 10 – NOTES PAYABLE

 

In May 2020, the Company was granted a loan (the “PPP Loan”) by a commercial bank in the amount of $1,040,400, pursuant to the Paycheck Protection Program features of the Coronavirus Aid, Relief, and Economic Security Act of 2020 (the “CARES Act”). The Company’s borrowings under the PPP Loan were eligible for loan forgiveness pursuant to the CARES Act. As of March 31, 2021, loan principal in the amount of $1,040,400, excluding accrued but unpaid interest of $8,922, was outstanding. In May 2021, the Company was notified by the lender that the Company’s obligations under the PPP Loan were forgiven effective May 25, 2021.

 

NOTE 11 – ACCRUED AND OTHER CURRENT LIABILITIES

 

Accrued and other current liabilities consist of the following:

 SUMMARY OF ACCRUED AND OTHER CURRENT LIABILITIES

   2022   2021 
   As of March 31, 
   2022   2021 
Deferred sales revenues  $547,217   $1,449,359 
Liability associated with uncertain tax positions   921,987    904,643 
Accrued severance expense   -    700,000 
Payroll and employee benefits   478,360    523,454 
Settlement liability, current portion   341,919    376,921 
Lease liability, current portion   134,578    373,398 
Other operational accruals   655,721    499,639 
Accrued and other current liabilities  $3,079,782   $4,827,414 

 

Lease liability, current portion, represent obligations due withing one year under operating leases for office space, automobiles, and office equipment. See Note 13 – “LEASES” below for more information.

 

NOTE 12 – CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consists of the following:

 

   Maturity  Interest   Conversion Price   As of March 31, 
Issuance Date  Date  Rate   (per share)   2022   2021 
April 2021  April 2024   8%  $0.20   $30,000,000   $- 
October 2017  October 2022   12%  $0.15    50,000    50,000 
April 2018  April 2021   0%  $0.01    -    100,000 
Total convertible notes payable         30,050,000    150,000 
Less: unamortized debt discount and deferred financing costs         20,151,230    15,607 
Subtotal         9,898,770    134,393 
Less: current portion of convertible notes payable         9,898,770    99,631 
Long-term convertible notes payable        $-   $34,762 

 

The Company’s convertible notes are convertible, at the option of the holder, into shares of the Company’s Common Stock at the conversion prices indicated above. The April 2018 convertible note was paid in full in March 2022.

 

In October 2017, the Company issued a Convertible Promissory Note in the principal amount of $50,000 (the “Note”) to HWH International, Inc (“HWH” or the “Holder”). HWH is affiliated with Heng Fai Ambrose Chan, who in April 2020 became a Director of the Company. The Note is convertible into 333,333 shares of the Company’s Common Stock. Concurrent with issuance of the Note, the Company issued to HWH a detachable warrant to purchase up to an additional 333,333 shares of the Company’s Common Stock, at an exercise price of $0.15 per share. Under the terms of the Note and the detachable stock warrant, the Holder is entitled to certain financing rights. If the Company enters into more favorable transactions with a third-party investor, it must notify the Holder and may have to amend and restate the Note and the detachable stock warrant to be identical. HWH has informed the Company that it believes that during the term of the Note, the Company has granted more favorable financing terms to third-party lenders. As of the date of this Annual Report, the Company and HWH are evaluating alternative options to settle this Note in the foreseeable future.

 

19
 

 

In April 2021, the Company and Decentralized Sharing Systems, Inc. (“DSSI”) entered into a Securities Purchase Agreement, pursuant to which the Company issued: (a) a Convertible Promissory Note in the principal amount of $30.0 million (the “Note”) in favor of DSSI, and (b) a detachable Warrant to purchase up to 150,000,000 shares of the Company’s Class A Common Stock, at $0.22 per share, and DSSI loaned to the Company $30.0 million. DSSI, is a subsidiary of DSS, Inc. (formerly Document Security Systems, Inc.) (“DSS”), and, together with DSS, is a majority shareholder of the Company. Under the terms of the loan, the Company agreed to pay to DSSI a loan origination fee of $3.0 million, payable in shares of the Company’s Class A Common Stock, at the rate of $0.20 per share. The Note bears interest at the annual rate of 8% and matures on April 5, 2024, subject to certain acceleration provisions upon the occurrence of an Event of Default, as defined in the Note. In addition, the Note is payable on demand by the holder. Accordingly, the Company classifies as current its obligation under the Note. At any time during the term of the Note, all or part of the Note, including the principal amount less unamortized prepaid interest, if any, plus any accrued interest can be converted into shares of the Company’s Class A Common Stock at the rate of $0.20 per share, at the option of the holder. Interest on the Note is pre-payable annually in cash or in shares of the Company’s Class A Common Stock, at the option of the Company, except that interest for the first year is pre-payable in shares of the Company’s Class A Common Stock, at the rate of $0.20 per share.

 

In connection with the issuance of the Note and the detachable Warrant, the Company allocated $15.0 million of the net proceeds from the loan to the detachable Warrant, allocated $12.0 million of the net proceeds to the beneficial conversion feature embedded in the Note and recognized deferred financing costs of $3.0 million. The resulting debt discount and the deferred financing costs are being amortized into interest expense over the term of the note (three years). During the fiscal year ended March 31, 2022, the Company issued 27,000,000 shares of its Class A Common Stock to DSSI, including 15,000,000 shares in payment of the loan origination fee discussed above and 12,000,000 shares in prepayment of interest for the first year. In connection therewith, the Company recognized a deemed dividend of $1,080,000 for the excess of the fair value of the shares issued over the amounts settled.

 

In the fiscal year ended March 31, 2022, and 2021, interest expense associated with the Company’s convertible notes was $2.4 million and $5,507, excluding amortization of debt discounts and deferred financing fees of $9.9 million and $18,647, respectively. These amounts are included in interest expense, net, in our consolidated statements of operations.

 

NOTE 13 – LEASES

 

The Company leases space for its corporate headquarters, warehouse space, automobiles, and office and other equipment, under lease agreements classified as operating leases. The Company has remaining lease terms of approximately 1 to 10 years on the remaining Leases. Leases with an initial term in excess of 12 months are recognized on the consolidated balance sheet based on the present value of future lease payments over the defined lease term at the lease commencement date. Future lease payments were discounted using an implicit rate of 10% to 12% in connection with most leases.

 

20
 

 

The following information pertains to the Company’s leases as of the balance sheet dates indicated:

 

Assets  Classification  2022   2021 
      As of March 31, 
Assets  Classification  2022   2021 
Operating leases  Right-of-use assets, net  $593,389   $428,075 
Total lease assets     $593,389   $428,075 
              
Liabilities             
Operating leases  Accrued and other current liabilities  $134,578   $373,398 
Operating leases  Lease liability, long-term   461,515    77,810 
Total lease liabilities     $596,093   $451,208 

 

Expense pertaining to the Company’s leases for the periods indicated is as follows:

 

      Fiscal Year Ended March 31, 
Lease cost  Classification  2022   2021 
Operating lease cost  General and administrative expenses  $585,015   $495,272 
Operating lease cost  Depreciation and amortization   -    - 
Operating lease cost  Interest expense, net   -    - 
Total lease cost     $585,015   $495,272 

 

The Company’s lease liabilities are payable as follows:

 

Twelve months ending March 31,   Amount 
2023   $154,310 
2024    96,944 
2025    99,458 
2026    102,231 
2027    105,048 
Thereafter    258,025 
Total remaining payments    816,016 
Less imputed interest    219,923 
Total lease liability   $596,093 

 

21
 

 

NOTE 14 – INCOME TAXES

 

Our consolidated provision for (benefit from) income taxes is as follows:

 

           
   Fiscal Year Ended March 31, 
   2022   2021 
Current:        
Federal  $(2,098,199)  $(326,121)
State and local   100,568    268,474 
Foreign   -    - 
Total current   (1,997,631)   (57,647)
Deferred:          
Federal   (1,038,359)   (536,862)
State and local   -     - 
Foreign   -     - 
Total deferred   (1,038,359)   (536,862)
Total consolidated income tax benefit  $(3,035,990)  $(594,509)

 

Our consolidated effective income tax rate reconciliation is as follows:

 

           
   Fiscal Year Ended March 31, 
   2022   2021 
Federal statutory rate   21.0%   21.0%
State and local income taxes   (0.5)   (11.6)
Prior period adjustments   -    45.6 
Change in valuation allowance for NOL carry-forwards   (6.7)   (5.3)
Effect of change in uncertain tax positions   -    (49.4)
Stock warrant transactions and other items   1.3    32.2 
Effective income tax rate   15.1%   32.5%

 

Our deferred tax asset (liability) is as follows:

 

         
   As of March 31, 
Deferred tax assets:  2022   2021 
Share-based compensation  $972,043   $873,970 
Accruals and reserves not currently deductible   649,113    247,348 
Impairment of investments and inventory   660,904    674,112 
Other   141,349    87,093 
Total deferred tax assets   2,423,409    1,882,523 
Less: valuation allowance   (2,342,204)   - 
Total deferred tax assets, net of valuation allowance   81,205    1,882,523 
Deferred tax liability:          
Other   -    9,353 
Total deferred tax liability   -    9,353 
Total consolidated deferred tax (liability) assets, net  $81,205  $1,873,170 

 

During the fiscal year ended March 31, 2022, the Company recognized a valuation allowance of $2.3 million in connection with certain deferred tax assets because of significant uncertainty about the Company’s ability to generate sufficient earnings in the foreseeable future to realize such assets. During the fiscal year ended March 31, 2022, and 2021, the Company recognized, in the aggregate, $491,496 and $91,931, respectively, in deferred income tax benefits in connection with certain foreign start-up operation. In addition, the Company recognized a valuation allowance of $491,496 and $91,931, respectively, in connection with the associated deferred tax assets because these star-up operations do not yet have a history of earnings and profits.

 

22
 

 

The Company has adopted the comprehensive model for how an entity should recognize, measure, present, and disclose in its financial statements uncertain tax positions that it has taken or expects to take on a tax return, consistent with ASC 740. Accordingly, the Company recognizes the impact of tax positions that meet a “more likely than not” threshold, based on the technical merits of the position. The tax benefits recognized in the consolidated financial statements from such a position is measured based on the largest benefit that has a greater than fifty percent likelihood of being realized upon ultimate settlement. As of March 31, 2022, and 2021, the Company had recognized a liability of $17,334 and $904,643, respectively, related to uncertain income tax positions, which is reported in other current liabilities. As of March 31, 2022, and 2021, the Company had unrecognized tax benefits of $921,977 and $904,643, respectively, that, if recognized, would impact the Company’s effective tax rate.

 

A reconciliation of the Company’s unrecognized tax benefits for the years indicated is as follows:

 

   Fiscal Year Ended March 31, 
   2022   2021 
Balance at beginning of fiscal year  $904,643   $- 
Additions for tax positions related to the current year   17,334    - 
Additions for tax positions of prior years   -    904,643 
Reductions of tax positions of prior years   -    - 
Settlements   -    - 
Balance at end of fiscal year  $921,977   $904,643 

 

The company recognizes interest and/or penalties related to uncertain tax positions in current income tax expense. For the year ended March 31, 2022, and 2021, the Company had recognized accrued interest and penalties, in the aggregate, of $121,790 and $334,332, respectively. Although it is not reasonably possible to estimate the amount by which unrecognized tax benefits may increase or decrease in the next twelve months due to uncertainties regarding timing and outcome of any examinations, the Company is evaluating alternatives that may impact the recognition of uncertain tax positions in the next twelve months.

 

The Company files consolidated federal income tax returns in the United States and files income tax returns in various state and foreign jurisdictions. As of March 31, 2022, the Company’s income tax returns for the following tax years remained subject to examination:

 

Tax Jurisdiction  Open Years 
United States   20162021 
Republic of Korea   2021 
Other Countries   N/A 

 

NOTE 15 – RELATED PARTY TRANSACTIONS

 

DSS, Inc., and Decentralized Sharing Systems, Inc.

 

In July 2020, the Company and Heng Fai Ambrose Chan, a Director of the Company, entered into a Stock Purchase and Share Subscription Agreement (the “SPA Agreement”) pursuant to which Mr. Chan invested $3.0 million in the Company and the Company agreed to issue 30.0 million shares of the Company’s Class A Common Stock and a fully vested Stock Warrant to purchase up to 10.0 million shares of the Company’s Class A Common Stock at an exercise price of $0.20 per share. Concurrently with the SPA Agreement, Mr. Chan and DSS, then a major shareholder of the Company, entered into an Assignment and Assumption Agreement pursuant to which Mr. Chan assigned to DSS all interests in the SPA Agreement. In July 2020, the Company issued 30.0 million of its Class A Common Stock pursuant to the SPA Agreement. The Stock Warrant issued pursuant to the SPA Agreement expires on the third anniversary from the issuance date, unless exercised earlier.

 

In April 2021, the Company and DSSI entered into a Securities Purchase Agreement, pursuant to which DSSI granted a $30.0 million loan to the Company in exchange for: (a) a Convertible Promissory Note in the principal amount of $30.0 million (the “Note”) in favor of DSSI, and (b) a detachable Stock Warrant to purchase up to 150,000,000 shares of the Company’s Class A Common Stock, at $0.22 per share. At any time during the term of the Note, all or part of the Note, including the principal amount less unamortized prepaid interest, if any, plus any accrued interest can be converted into shares of the Company’s Class A Common Stock at the rate of $0.20 per share, at the option of the holder. Under the terms of the loan agreement, the Company agreed to pay to DSSI a loan origination fee of $3.0 million, payable in shares of the Company’s Class A Common Stock, with the number of shares to be calculated at the rate of $0.20 per share. In April 2021, Sharing Services issued 27.0 million shares of its Class A Common Stock to DSSI, including 15.0 million shares in payment of the loan origination fee and 12.0 million shares in prepayment of interest on a loan for the first year, as more fully discussed in Note 11 above.

 

23
 

 

In December 2021, the Company and DSSI entered into a Stock Purchase and Share Subscription Agreement pursuant to which DSSI invested $3,000,000 in the Company in exchange for 50.0 million shares of Class A Common Stock (the “Shares”) and stock warrants (the “Stock Warrants”) to purchase up to 50.0 million shares of the Company’s Class A Common Stock. The Stock Warrants are fully vested, have a term of five (5) years and are exercisable at any time prior to expiration, at the option of DSSI, at a per share price equal to $0.063. On the effective date of the Stock Purchase and Share Subscription Agreement, the closing price for the Company’s common stock was $0.075 per share and the Company recognized a deemed dividend of $2.3 million in connection with the transaction.

 

In January 2022, the Company and DSS who, together with its subsidiaries, is currently a majority shareholder of the Company, entered into a one-year Business Consulting Agreement (the “Consulting Agreement”) pursuant to which the DSS will provide to the Company certain consulting services, as defined in the Consulting Agreement. The Consulting Agreement may be terminated by either party on a 60-day’s written notice. In connection with the Consulting Agreement, the Company agreed to pay DSS and flat monthly fee of sixty thousand dollars ($60,000) and DSS received a fully vested detachable Stock Warrant to purchase up to 50.0 million shares of the Company’s Class A Common Stock, at the exercise price of $0.0001 per share. On the effective date of the Consulting Agreement, the closing price of the Company’s common stock was $0.07 per share and the fair value of the Stock Warrant was $3.5 million. The fair value of the Stock Warrant is being recognized as consulting expense over the term of one year. During the fiscal year ended March 31, 2022, the Company recognized consulting expense of $766,415 in connection with the Consulting Agreement. In February 2022, the Company issued 50.0 million shares of its Common Stock Class A to DSS in connection with exercise of the Stock Warrant.

 

As of March 31, 2022, DSS and its affiliates owned, in the aggregate, 191.9 million shares of the Company’s Class A Common Stock, excluding 210.0 million shares issuable upon the exercise of warrants held by DSS and 150.0 million shares issuable upon conversion of the Note discussed in the third preceding paragraph. Heng Fai Ambrose Chan, Frank D. Heuszel, and John (“JT”) Thatch, each a Director of the Company, also serve on the Board of Directors of DSS. Mr. Chan serves as Chairman of the Board of Directors of the Company. Mr. Thatch also serves as President, CEO and Vice Chairman of the Board of Directors of the Company.

 

Alset Title Company, Inc.

 

In December 2021, Sharing Services, through one of its subsidiaries, purchased an office building in Lindon, Utah for $8,942,640. In connection therewith, Alset Title Company, Inc. (“Alset Title”), a subsidiary of DSS, acted as escrow and closing agent for the transaction, at no cost. DSS, together with its subsidiaries, is a majority shareholder of the Company.

 

Hapi Café, Inc.

 

In November 2021, Sharing Services and Hapi Café, Inc, a company affiliated with Heng Fai Ambrose Chan, a Director of the Company, entered into a Master Franchise Agreement pursuant to which Sharing Services acquired the exclusive franchise rights in North America to the brand “Hapi Café.” Under the terms, Sharing Services, directly or through its subsidiaries, has the right to operate no less than five (5) corporate-owned stores and can offer to the public sub-franchise rights to own and operate other stores, subject to the terms and conditions contained in the Master Franchise Agreement.

 

HWH International, Inc.

 

In October 2017, Sharing Services issued a Convertible Promissory Note in the principal amount of $50,000 (the “Note”) to HWH International, Inc (“HWH” or the “Holder”). HWH is affiliated with Heng Fai Ambrose Chan, who became a Director of the Company in April 2020. The Note is convertible into 333,333 shares of the Company’s Common Stock. Concurrent with issuance of the Note, the Company issued to HWH a detachable stock warrant to purchase up to an additional 333,333 shares of the Company’s Common Stock, at an exercise price of $0.15 per share. Under the terms of the Note and the detachable stock warrant, the Holder is entitled to certain financing rights. If the Company enters into more favorable transactions with a third-party investor, it must notify the Holder and may have to amend and restate the Note and the detachable stock warrant to be identical. As of the date of this Quarterly Report, the Company and HWH are evaluating alternative options to settle this Note in the foreseeable future.

 

HWH World, Inc.

 

A subsidiary of the Company operating in the Republic of Korea subleases office space from HWH World, Inc. (“HWH World”), a subsidiary of DSS and a company affiliated with Heng Fai Ambrose Chan, a Director of the Company. Pursuant to the terms of the sublease agreement, the Company recognized a right-of-use asset and an operating lease liability of $261,835 in connection therewith. In fiscal year ended March 31, 2022, the Company recognized expense of $222,092 in connection this lease. As of March 31, 2022, accounts payable includes payments due to HWH World under the lease of $213,742. In May 2022, the Company and HWH World amended the related sublease agreement to significantly reduce the space subleased by the Company and the related rent obligation.

 

In September 2021, the Company and HWH World entered into an Advisory Agreement pursuant to which the Company provides strategic advisory services to HWH World in connection with its North America expansion plans in exchange for a monthly fee of $10,000. During the fiscal year ended March 31, 2022, the Company recognized consulting income of $76,700 in connection therewith.

 

24
 

 

Impact Biomedical, Inc.

 

In the fiscal year ended March 31, 2022, a wholly owned subsidiary of the Company purchased health and wellness products from Impact Biomedical, Inc., a subsidiary of DSS, in the aggregate amount of $111,414.

 

K Beauty Research Lab. Co., Ltd

 

In the fiscal year ended March 31, 2022, a wholly owned subsidiary of the Company purchased skin care products manufactured by K Beauty Research Lab. Co., Ltd (“K Beauty”), a South Korean-based supplier of skin care products that is affiliated with Heng Fai Ambrose Chan, a Director of the Company, in the aggregate amount of $2.3 million. The Company’s affiliates operating in Asia intend to distribute skin care and other products in South Korea and other countries, including skin care products procured from K Beauty, as part of the Company’s previously announced strategic growth plans.

 

Premier Packaging Corporation

 

In the fiscal year ended March 31, 2022, a wholly owned subsidiary of the Company issued purchase orders to Premier Packaging Corporation, a subsidiary of DSS, to acquire printed packaging materials in the aggregate amount of $155,693.

 

Alchemist Holdings, LLC

 

In February 2020, the Company, Alchemist Holdings, LLC (“Alchemist”), and a former Company officer entered into a Settlement Accommodation Agreement (the “Accommodation Agreement”) pursuant to which Alchemist and the former Company officer agreed to transfer to the Company 22.7 million shares of the Company’s Common Stock held by Alchemist, in settlement of certain obligations to the Company. Under the terms of the Accommodation Agreement, Alchemist and the former Company officer also agreed to transfer to the Company 15.6 million shares of the Company’s Common Stock held by Alchemist, to offset certain legal and other expenses incurred by the Company in connection with various related-party legal claims. Accordingly, in the fiscal year ended March 31, 2021, the Company and Alchemist caused the transfer to the Company, in the aggregate, of 38.3 million shares of the Company’s Common Stock then held by Alchemist, and the Company retired such redeemed shares.

 

In June 2020, the Company and the former Company officer discussed in the preceding paragraph entered into a Settlement Accommodation Agreement and an Amended and Restated Founder Consulting Agreement pursuant to which the Company and the former officer agreed to settle all existing disputes between them, the former officer agreed to continue to provide certain consulting services to the Company, and the Company agreed to pay certain amounts to the former officer. The Company has recognized a settlement liability of $2.0 million in connection therewith. As of March 31, 2022, the settlement liability balance is $715,596.

 

The Company subleases warehouse and office space from Alchemist, a 10% shareholder of the Company. During the fiscal year ended March 31, 2022, and 2021, rent expense associated with such sublease agreement was $105,105 and $84,918, respectively.

 

American Premium Water Corporation

 

In July 2021, the Company and American Premium Water Corporation (“American Premium”) entered into a business consulting agreement pursuant to which the Company provides consulting services to American Premium in exchange for a monthly fee of $4,166. Mr. John “JT” Thatch, a director of the Company, also serves on the Board of Directors of American Premium. During the fiscal year ended March 31, 2022, the Company recognized consulting fee income of $33,328.

 

NOTE 16 - STOCKHOLDERS’ EQUITY – CAPITAL STOCK

 

Preferred Stock

 

The Company’s Board of Directors (the “Board”) has authorized the issuance of up to 200,000,000 shares of Preferred Stock, par value of $0.0001 per share. The Board may divide this authorization into one or more series, each with distinct powers, designations, preferences, and rights.

 

25
 

 

Series A Convertible Preferred Stock

 

The Board has authorized the issuance of up to 100,000,000 shares of Series A Convertible Preferred Stock (the “Series A Preferred Stock”). Shares of our Series A Preferred Stock are senior in rank to shares of our Series C Preferred Stock. The affirmative vote of the holders of 86% of the issued and outstanding shares of our Series A Preferred Stock is required for the Board: (i) to declare dividends upon shares of our Common Stock unless, with respect to cash dividends, the shares of our Series A Preferred Stock are to receive the same dividend as the common shares, on an as converted basis; (ii) to redeem the shares of our Series A Preferred Stock at a redemption price of $0.001 per share; (iii) to authorize or issue additional or other capital stock that is junior or equal in rank to shares of our Series A Preferred Stock with respect to the preferences as to distributions and payments upon the liquidation, dissolution, or winding up of the Company; and (iv) to amend, alter, change, or repeal any of the powers, designations, preferences, and rights of our Series A Preferred Stock. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series A Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.001 per share before any payment or distribution shall be made on our shares of Common Stock, or any other class of capital stock ranking junior to the Series A Preferred Stock. For a period of 10 years from the date of issuance, the holders of the Series A Preferred Stock may elect to convert each share of the Series A Preferred Stock into one share of the Company’s Common Stock. Each share of our Series A Preferred Stock is entitled to one vote when voting as a class or together with the shares of our Common Stock.

 

During the fiscal year ended March 31, 2021, stockholders converted an aggregate of 21,750,000 shares of the Company’s Series A Preferred Stock into an equal number of shares of the Company’s Common Stock. There were no similar conversions in the fiscal year ended March 31, 2022.

 

As disclosed in the notes to our consolidated financial statements for the fiscal year ended April 30, 2020, in the fiscal year 2019, the Company filed suit against Research & Referral BZ and two other parties concerning breach of contract, fraud, and statutory fraud in a stock transaction, violations of state securities laws and alter ego relating to a stock exchange/transfer transaction, involving the Company’s stock. In April 2020, the court issued a Final Default Judgment in favor of the Company finding Research and Referral, BZ liable for the Company’s claims of fraud in the inducement and statutory fraud in a stock transaction. Further, the court ordered that the stock transaction be rescinded, and the Company’s stock be returned to the Company, and the matter has been dismissed with prejudice. During the fiscal year ended March 31, 2022, the Company’s transfer agent received and cancelled the stock certificate and the Company retired 2,000,000 shares of the Company’s Series A Preferred Stock previously purportedly held by Research and Referral BZ.

 

As of March 31, 2022, and 2021, 3,100,000 shares and 5,100,000 shares, respectively, of the Company’s Series A Preferred Stock remain outstanding. The shares of the Company’s Series A Preferred Stock reported in the Company’s financial statements as of March 31, 2022, include 2,900,00 shares purportedly held by Research & Referral BZ, pending cancellation of the stock certificate when presented by Research & Referral BZ in the future.

 

Series B Convertible Preferred Stock

 

The Board has authorized the issuance of up to 10,000,000 shares of Series B Convertible Preferred Stock (the Series B Preferred Stock”). Issued and outstanding shares of our Series B Preferred Stock, if any, are senior in rank to shares of our Series A and Series C Preferred Stock. During the fiscal year ended March 31, 2021, all shares of the Company’s Series B Preferred Stock previously issued were converted into shares of the Company’s Class A Common Stock. As of March 31, 2022, and 2021, no shares of the Company’s Series B Preferred Stock remain outstanding.

 

Series C Convertible Preferred Stock

 

The Board has authorized the issuance of up to 10,000,000 shares of Series C Convertible Preferred Stock (the Series C Preferred Stock”). Shares of our Series C Preferred Stock are junior in rank to the Series A and Series B Preferred Stock. The affirmative vote of the holders of 86% of the issued and outstanding shares of our Series C Preferred Stock is required for the Board: (i) to declare dividends upon shares of our Common Stock unless, with respect to cash dividends, the shares of our Series C Preferred Stock are to receive the same dividend as the common shares, on an as converted basis; (ii) to redeem the shares of Series C Preferred Stock at a redemption price of $0.001 per share; (iii) to authorize or issue additional or other capital stock that is junior or equal in rank to our Series C Preferred Stock with respect to the preferences as to distributions and payments upon the liquidation, dissolution, or winding up of the Company; and (iv) to amend, alter, change, or repeal any of the powers, designations, preferences, and rights of the Series C Preferred Stock. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders of the Series C Preferred Stock are entitled to receive out of the assets of the Company the sum of $0.001 per share before any payment or distribution shall be made on our shares of Common Stock, or any other class of capital stock of the Company ranking junior to the Series C Preferred Stock. For a period of 10 years from the date of issuance, the holders of the Series C Preferred Stock may elect to convert each share of Series C Preferred Stock into one share of the Company’s Common Stock. Each share of our Series C Preferred Stock is entitled to one vote when voting as a class or together with shares of our Common Stock.

 

During the fiscal year ended March 31, 2022, and 2021, holders of 10,000 shares and 260,000 shares, respectively, of the Company’s Series C Preferred Stock converted their holdings into an equal number of shares of the Company’s Common Stock. As of March 31, 2022, and 2021, 3,220,000 shares and 3,230,000 shares of the Company’s Series C Preferred Stock remain outstanding.

 

26
 

 

Common Stock

 

The Board has authorized the issuance of up to 800,000,000 shares of Class A Common Stock and up to 10,000,000 shares of Class B Common Stock, each with a par value of $0.0001 per share. Holders of our Common Stock are entitled to dividends, subject to the rights of the holders of other classes of capital stock outstanding having priority rights with respect to dividends. At the time of this Annual Report, no shares of the Company’s Class B Common Stock remain outstanding. References to our “Common Stock” throughout this report include our Class A Common Stock and Class B Common Stock, unless otherwise indicated or the context otherwise requires.

 

In July 2020, in exchange for $3.0 million in cash, the Company issued 30.0 million shares of its Class A Common Stock and a fully vested Stock Warrant to purchase up to 10.0 million shares of the Company’s Class A Common Stock, at the exercise price of $0.20 per share, in connection with the previously disclosed SPA Agreement between the Company and DSSI (see Note 15 above). On the effective date of the SPA Agreement, the closing price for the Company’s common stock was $0.18 per share and the Company recognized a deemed dividend of $2.4 million in connection with this related-party transaction.

 

In April 2021, the Company issued 27.0 million shares of its Class A Common Stock to DSSI, including 15.0 million shares in payment of a loan origination fee and 12.0 million shares in prepayment of interest on a loan, as more fully discussed in Notes 11 and 14 above. On the effective date of the loan agreement, the closing price for the Company’s common stock was $0.24 per share and the Company recognized a deemed dividend of $1.1 million in connection with this related-party transaction.

 

In December 2021, the Company and DSSI entered into a Stock Purchase and Share Subscription Agreement pursuant to which DSSI invested $3.0 million in the Company in exchange for 50.0 million shares of Class A Common Stock and a Stock Warrant to purchase up to 50.0 million shares of the Company’s Class A Common Stock. On the effective date of the Stock Purchase and Share Subscription Agreement, the closing price for the Company’s common stock was $0.075 per share and the Company recognized a deemed dividend of $2.3 million in connection with this related-party transaction.

 

As discussed in Note 13 above, in January 2022, the Company and DSS entered into a one-year Business Consulting Agreement (the “Consulting Agreement”) pursuant to which the DSS will provide to the Company certain consulting services, as defined in the Consulting Agreement. In connection with the Consulting Agreement, the Company agreed to pay DSS and flat monthly fee of sixty thousand dollars ($60,000) and DSS received a fully vested detachable Stock Warrant to purchase up to 50.0 million shares of the Company’s Class A Common Stock, at the exercise price of $0.0001 per share. On the effective date of the Consulting Agreement, the fair value of the detachable Stock Warrant was $3.5 million which is being recognized as consulting expense over the term of the Consulting Agreement (one year). In February 2022, Sharing Services issued 50.0 million shares of its Common Stock Class A to DSS in connection with the exercise of such Stock Warrant.

 

During the fiscal year ended March 31, 2021, the Company also issued: (a) 10.0 million shares of its Class A Common Stock to Robert Oblon, a co-founder of the Company, pursuant to the previously disclosed Multi-Party Settlement Agreement, (b) 5.5 million shares in connection with the exercise of warrants by Company employees, and (c) 2.3 million shares in connection with the exercise of warrants by independent distributors of the Company.

 

During the fiscal year ended March 31, 2022, holders of 10,000 shares of the Company’s Series C Preferred Stock converted such holdings into an equal number of shares of the Company’s Class A Common Stock. In addition, during the fiscal year ended March 31, 2022, the Company issued: (a) 1.5 million shares in connection with the exercise of warrants by Company employees, and (b) 313,200 shares in connection with the exercise of warrants by independent distributors of the Company.

 

During the fiscal year ended March 31, 2021, the holders of 10.0 million shares of the Company’s Series B Preferred Stock and 10.0 million shares of the Company’s Class B Common Stock converted their holdings into an equal number of shares of the Company’s Class A Common Stock. In addition, during the fiscal year ended March 31, 2021, a then the purported holder of 20.0 million shares of the Company’s Series A Preferred Stock, converted such holdings into an equal number of shares of the Company’s Class A Common Stock, holders of 1.8 million shares of the Company’s Series A Preferred Stock converted such holdings into an equal number of shares of the Company’s Class A Common Stock, and holders of 260,000 shares of the Company’s Series C Preferred Stock converted such holdings into an equal number of shares of the Company’s Class A Common Stock.

 

As of March 31, 2022, and 2021, 288,923,969 shares and 160,100,769 shares, respectively, of our Class A Common Stock remained issued and outstanding. As of March 31, 2022, and 2021, there were no shares of the Company’s Class B Common Stock outstanding.

 

27
 

 

NOTE 17 – STOCK-BASED COMPENSATION

 

A subsidiary of the Company has awarded compensatory warrants to purchase shares of the Company’s common stock to its officers and employees (see Note 2 – “SIGNIFICANT ACCOUNTING POLICIES - Share-Based Payments” for more details) and warrants to purchase shares of the Company’s common stock to its independent sales force. Further, the Company from time to time, awards stock warrants to its consultants in exchange for services.

 

Stock Warrants

 

Stock Warrants Issued to Related Parties, Directors, Officers, and Employees

 

In the fiscal year ended March 31, 2021, the Company issued to Company directors, officers, and employees stock warrants to purchase, in the aggregate, up to 29,200,000 shares of its Common Stock, with an aggregate grant date fair value of $3.6 million. Some of the stock warrants outstanding as of March 31, 2022, are exercisable at a variable exercise price (see Note 2 – “SIGNIFICANT ACCOUNTING POLICIES - Share-Based Payments” for more details) pursuant to the related employment agreements.

 

As discussed in Note 14, in July 2020, the Company and Heng Fai Ambrose Chan, a Director of the Company, entered into a Stock Purchase and Share Subscription Agreement (the “SPA Agreement”) pursuant to which Mr. Chan agreed to invest $3.0 million in the Company in exchange for 30.0 million shares of the Company’s Class A Common Stock and a fully vested Stock Warrant to purchase up to 10.0 million shares of the Company’s Class A Common Stock at an exercise price of $0.20 per share. In July 2020, Mr. Chan assigned to DSS all interests in the SPA Agreement and the transactions contemplated in the SPA Agreement were completed. Mr. Chan is a Director of DSS.

 

In October 2017, the Company issued a convertible note in the principal amount of $50,000 to HWH International, Inc (“HWH”) and a detachable stock warrant to purchase up to 333,333 shares of the Company’s Common Stock, at an exercise price of $0.15 per share. The Note is convertible into 333,333 shares of the Company’s Common Stock and expires in October 2022. HWH is affiliated with Heng Fai Ambrose Chan, who in April 2020 became a Director of the Company.

 

The following table summarizes the activity relating to the Company’s stock warrants held by Related Parties (all of which are fully vested) (See Note 15 above for more details):

 

   Number of
Warrants
   Weighted Average Exercise Price   Weighted Average Remaining Term 
Outstanding at April 30, 2020   333,333   $0.15    2.4 
Granted   10,000,000         - 
Exercised        -    - 
Expired or forfeited   -         - 
Outstanding at March 31, 2021   10,333,333   $0.20    2.3 
Granted   250,000,000    0.14    - 
Exercised   (50,000,000)   0.0001      
Expired or forfeited   -    -    - 
Outstanding at March 31, 2022   210,333,333   $0.18    4.1 

 

28
 

 

The following table summarizes the activity relating to the Company’s vested and unvested stock warrants held by Directors, Officers, and Employees:

 

   Number of
Warrants
   Weighted Average Exercise Price   Weighted Average Remaining Term 
Outstanding at April 30, 2020   22,000,000   $0.002    4.2 
Granted   29,200,000    0.13    - 
Exercised   (9,000,000)   0.0001    - 
Expired or forfeited   (18,125,000)   0.0001    - 
Outstanding at March 31, 2021   24,075,000   $0.11    3.5 
Granted   -    -    - 
Exercised   (1,500,000)   0.13    - 
Expired or forfeited   (2,875,000)   0.19    - 
Outstanding at March 31, 2022   19,700,000   $0.03    2.6 
Less: unvested at March 31, 2022   5,625,000   $0.02    2.1 
Vested at March 31, 2022   14,075,000   $0.04    2.8 

 

Stock Warrants Issued to Our Independent Sales Force

 

In the fiscal year ended March 31, 2021, the Company issued fully vested warrants to purchase up to 4,013,000 shares of its Common Stock to members of its independent sales force, with a fair value of $1.5 million. The warrants are exercisable for a period ranging from one to two years from the issuance date, at the exercise price ranging from $0.01 per share to $0.25 per share. In the fiscal year ended March 31,2022, and 2021, warrants held by independent distributors to purchase up to 1,507,200 shares and 2,066,600 shares, respectively, of the Company’s Common Stock expired or were otherwise terminated or forfeited. See Note 2 – “SIGNIFICANT ACCOUNTING POLICIES - Sales Commissions” for more details.

 

The following table summarizes the activity relating to the Company’s stock warrants held by members of the Company’s independent sales force (all of which are fully vested):

 

   Number of
Warrants
   Weighted Average Exercise Price   Weighted Average Remaining Term 
Outstanding at April 30, 2020   4,390,600   $0.04    2.5 
Granted   4,013,000    0.01    - 
Exercised   (2,339,000)   0.01    - 
Expired or forfeited   (2,066,600)   0.25    - 
Outstanding at March 31, 2021   3,998,000   $0.09    1.4 
Granted   2,400    0.01    - 
Exercised   (313,200)   0.01    - 
Expired or forfeited   (1,507,200)   0.03    - 
Outstanding at March 31, 2022   2,180,000   $0.02    1.2 

 

29
 

 

Stock Warrants Held by Our Consultants

 

From time to time, the Company has granted fully vested warrants to purchase shares of its Common Stock to its consultants in exchange for services. The following table summarizes the activity relating to the Company’s stock warrants held by Company consultants (all of which are fully vested):

 

   Number of
Warrants
   Weighted Average Exercise Price   Weighted Average Remaining Term 
Outstanding at April 30, 2020   160,000   $1.97    3.80 
Granted   -    -    - 
Exercised   -    -    - 
Expired or forfeited   (60,000)   0.25    - 
Outstanding at March 31, 2021   100,000   $3.00    1.00 
Granted   -    -    - 
Exercised, expired or forfeited   -    -    - 
Outstanding at March 31, 2022   100,000   $3.00    0.02 

 

The following table summarizes additional information relating to all stock warrants outstanding and warrants exercisable as of March 31, 2022:

 

All Warrants Outstanding   All Warrants Exercisable 
    Weighted
Average Remaining
   Weighted
Average
       Weighted
Average
 
Number of
Shares
   Contractual
life (in years)
   Exercise
Price
   Number of
Shares
   Exercise
Price
 
 3,000,000    5.40   $0.0001    3,000,000   $0.0001 
 16,700,000    2.10   $0.04    11,075,000   $0.04 
 210,000,000    4.1   $0.18    210,000,000   $0.18 
 2,180,000    1.20   $0.02    2,180,000   $0.02 
 333,333    0.50   $0.15    333,333   $0.15 
 100,000    0.02   $3.00    100,000   $3.00 
 232,313,333              226,688,333      

 

NOTE 18 - COMMITMENTS AND CONTINGENCIES

 

Contingencies

 

Legal Proceedings – Related-Party Matters and Settlement Liability

 

In February 2020, the Company, Alchemist, and a former officer of the Company entered into a Settlement Accommodation Agreement and an Amended and Restated Founder Consulting Agreement pursuant to which the Company and the former officer agreed to settle all existing disputes between them, the former officer agreed to continue to provide certain consulting services to the Company, and the Company agreed to pay certain amounts to the former officer. The Company has recognized a settlement liability of $2.0 million in connection therewith. As of March 31, 2022, the settlement liability balance is $715,596. See Note 15 – “RELATED PARTY TRANSACTIONS – Alchemist Holdings, LLC” above for more information.

 

Legal Proceedings – Other Matters

 

The Company from time to time is involved in various claims and lawsuits incidental to the conduct of its business in the ordinary course. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated financial position, results of operations or cash flows.

 

30
 

 

(a)

Case No. 4:20-cv-00946; Dennis Burback, Ken Eddy and Mark Andersen v. Robert Oblon, Jordan Brock, Jeff Bollinger, Four Oceans Global, LLC, Four Oceans Holdings, Inc., Alchemist Holdings, LLC, Elepreneurs U.S., LLC, Elevacity U.S., LLC, Sharing Services Global Corporation, Custom Travel Holdings, Inc., and Does 1-5, pending in the United States District Court for the Eastern District of Texas. On December 11, 2020, three investors in Four Oceans Global, LLC filed a lawsuit against the Company, its affiliated entities, and other persons and entities related to an investment made by the three investors in 2015. The Company and its affiliated entities have filed an answer denying the three investors’ claims. Plaintiffs filed a first amended complaint on October 14, 2021. This matter remains pending as of March 31, 2022.

   
(b)

AAA Ref. No. 01-20-0019-3907; Sharing Services Global Corporation, Elevacity Holdings, LLC, Elevacity U.S., LLC, Elepreneurs Holdings, LLC and Elepreneurs U.S., LLC v. Robert Oblon, pending before the American Arbitration Association. On December 30, 2020, the Company and its affiliated companies filed an arbitration complaint against Robert Oblon for breach of contract and a declaratory judgment relating to the Multi-Party Settlement Agreement with Robert Oblon. See Note 20, SUBSEQUENT EVENTS below.

   
(c)

Case No. 4:20-cv-00989; Sharing Services Global Corporation, Elevacity Holdings, LLC, Elevacity U.S., LLC, Elepreneurs Holdings, LLC and Elepreneurs U.S., LLC v. Robert Oblon, pending in the in the United States District Court for the Eastern District of Texas. On December 30, 2020, the Company and its affiliated companies filed a lawsuit against Robert Oblon seeking injunctive relief relating to the Multi-Party Settlement Agreement with Robert Oblon. This matter is a companion case to the AAA arbitration proceeding described in paragraph (b) above and, while it remains pending as of March 31,2022, further action in this case has been stayed by court order, pending final adjudication of the referenced AAA arbitration proceeding. See Note 20, SUBSEQUENT EVENTS below.

   
(d)

Case No. 4:21-cv-00026; Elepreneurs Holdings, LLC d/b/a Elepreneur, LLC, Elepreneurs U.S., LLC d/b/a Elepreneurs, LLC, and SHRG IP Holdings, LLC v. Lori Ann Benson, Andrea Althaus and Lindsey Buboltz, pending in the United States District Court for the Eastern District of Texas. On December 31, 2020, the Company filed suit against three former distributors and obtained injunctive relief from the 429th Judicial District of Collin County, Texas. The lawsuit was removed by the three former distributors to federal court. The Company subsequently obtained injunctive relief from the federal court. The matter remains pending as of March 31, 2022.

   
(e)

Case No. 4:21-cv-00183; Sharing Services Global Corporation f/k/a Sharing Services, Inc., Elepreneurs Holdings, LLC n/k/a Elevacity Holdings, LLC, Elepreneurs U.S., LLC n/k/a Elevacity U.S., LLC and SHRG IP Holdings, LLC v. AmplifeiIntl, LLC d/b/a HAPInss and HAPInssBrands, LLC pending in the United States District Court for the Eastern District of Texas. On March 5, 2021, the Company and its affiliated entities filed suit against a newly formed competitor for various claims including trademark infringement, trade secret violations, unfair competition under state and federal law as well as tortious interference with contracts and business relationships. See Note 20, SUBSEQUENT EVENTS below.

   
(f) Cause No. 429-01137-2022; Elevacity U.S., LLC d/b/a The Happy Co. and Elepreneurs U.S., LLC d/b/a Elepreneurs, LLC v. Mark Willodson, Judy Willodson and Valentus, Inc., pending in the 429th Judicial District Court of Collin County, Texas. On March 9, 2022, the Company filed suit against a competitor and former distributors. The matter remains pending as of March 31, 2022.
   
(g) Case No. 4:22-cv-00042; Elevacity U.S., LLC d/b/a The Happy Co. and Elepreneurs U.S., LLC d/b/a Elepreneurs, LLC v. Brian Christopher Schweda, Jr., pending in the United States District Court for the Eastern District of Texas. On January 20, 2022, the Company filed suit against a former distributor. The matter remains pending as of March 31, 2022.
   
(h) Case No. 4:22-cv-00047; Elevacity U.S., LLC d/b/a The Happy Co. and Elepreneurs U.S., LLC d/b/a Elepreneurs, LLC v. Kimberley McLean, pending in the United States District Court for the Eastern District of Texas. On January 20, 2022, the Company filed suit against a former distributor. The matter remains pending as of March 31, 2022.

 

31
 

 

NOTE 19 - BUSINESS SEGMENT AND GEOGRAPHIC AREA INFORMATION

 

Business Segments

 

As of March 31, 2022, and 2021, the Company, through its subsidiaries, markets and sells its products and services to consumers, through its independent sales force and proprietary websites, and to its independent distributors. The Company has determined its reportable segments are: (a) the sale of health and wellness products, and (b) the sale of other products and services. The Company’s determination of its reportable segments is based on how its chief operating decision maker manages the business.

 

The Company’s segment information is as follows:

 

   2022   2021 
   Fiscal Year Ended March 31, 
   2022   2021 
Net sales          
Health and wellness products  $32,147,330   $64,046,966 
Other   2,276,984    764,185 
Total net sales  $34,424,314   $64,811,151 
Operating earnings (loss):          
Segment gross profit:          
Health and wellness products  $22,059,788   $45,997,828 
Other   1,562,655    548,829 
Total segment gross profit   23,622,443    46,546,657 
Selling and marketing expenses   17,239,655    29,740,974 
General and administrative expenses   19,714,963    18,983,209 
Consolidated operating loss  $(13,332,175)  $(2,177,526)
Total Assets:          
Health and wellness  $13,729,219   $22,772,217 
Corporate   29,435,505    464,739 
Consolidated total assets  $43,164,724   $23,236,956 
Payments for property and equipment:          
Health and wellness  $208,952   $907,891 
Corporate   9,123,016    6,445 
Consolidated payments for property and equipment  $9,331,967   $914,336 
Depreciation and amortization expense:          
Health and wellness  $94,459   $155,085 
Corporate   560,808    8,163 
Consolidated depreciation and amortization  $655,267   $163,248 

 

Geographic Area Information

 

Our consolidated net sales, by geographic area, were as follows:

 

  2022   2021 
   Fiscal Year Ended March 31, 
Country  2022   2021 
United States  $29,803,258   $60,961,369 
Canada   2,446,330    3,214,633 
Republic of Korea   1,706,367    - 
Other   468,359    635,149 
   $34,424,314   $64,811,151 

 

32
 

 

Our consolidated total assets, by geographic area, were as follows:

 

  2022   2021 
   Fiscal Year Ended March 31, 
Country  2022   2021 
United States  $39,865,782   $20,941,018 
Republic of Korea   2,663,149    1,200,214 
Other   635,793    1,095,725 
   $43,164,724   $23,236,956 

 

NOTE 20 - SUBSEQUENT EVENTS

 

Legal Proceedings - In April 2022, the parties to the matters discussed in Items (b), (c) and (e) in Note 17 – COMMITMENTS AND CONTINGENCIES – Legal Proceedings – Other Matters above reached a settlement, and the related legal and arbitration proceedings were dismissed.

 

Federal Income Tax Refund - In April 2022, the Company received a federal income tax refund in the amount of $300,000.

 

Modification of Debt - On June 15, 2022, the Company and DSSI which, together with DSS, is a majority shareholder of the Company, entered into an agreement pursuant to which the Company issued, to DSSI: (a) a two-year Convertible, Advancing Promissory Note in the principal amount of $27.0 million (the “2022 Note”) in favor of DSSI and (b) a detachable Warrant to purchase up to 818,181,819 shares of the Company’s Class A Common Stock at the exercise price of $0.033 per share. The 2022 Note bears interest at the annual rate of 8% and is due and payable on demand or, if no demand, on May 1, 2024. At any time during the term of the 2022 Note, all or part of the Note may be converted into up to 818,181,819 shares of the Company’s Class A Common Stock, at the option of the holder. Under the terms of the agreement, the Company agreed to pay to DSSI a loan origination fee of $270,000. In addition, DSSI agreed to surrender to the Company all DSSI’s rights pursuant to: (a) a certain Convertible Promissory Note in the principal amount of $30.0 million issued by the Company in April 2021 in favor of DSSI, and (b) a certain detachable Warrant to purchase up to 150,000,000 shares of the Company’s Class A Common Stock, at $0.22 per share, issued concurrently with such $30.0 million note.

 

Financing of Lindon, Utah Facility – On June 15, 2022, Linden Real Estate Holdings, LLC, a wholly owned subsidiary of the Company, American Pacific Bancorp, Inc. (“APB”), and the Company entered a Loan Agreement pursuant to which APB loaned to the Company for approximately $5.7 million. The loan bears interest at the annual rate of 8%, matures on June 1, 2024, and is secured by a first mortgage interest on the Company’s Lindon, Utah office building. In connection with the loan, the Company received net proceeds of $5,522,829 from APB on June 17, 2022. APB is a subsidiary of Alset eHome International Inc (NASDAQ:AEI). Heng Fai Ambrose Chan, and Frank D. Heuszel, each a Director of the Company, also serve on the Board of Directors of APB, and Mr. Chan also serves on the Board of Directors of Alset eHome International.

 

Settlement With Former Officer - As disclosed in Note 14 above, in February 2020, the Company and a former officer of the Company entered into an Amended and Restated Founder Consulting Agreement (the “Co-Founder’s Agreement”) pursuant to which the former officer agreed to continue to provide certain consulting services to the Company, and the Company agreed to pay certain periodic amounts to the former officer. At that time, the Company recognized a settlement liability of $2.0 million in connection therewith. As of March 31, 2022, the settlement liability balance was $715,596. In May 2022, the Company and certain of its subsidiaries, on the one hand, and the former officer and certain entities affiliated with the former officer, on the other hand, entered into a Confidential Settlement Agreement with Mutual Releases (the “May 2022 Settlement Agreement”) pursuant to which the parties amicably settled all claims and disputes among them; (b) the former officer sold to the Company 26,091,136 shares of the Company’s common stock then under the voting and dispositive control of the former officer; (c) the Company made a one-time payment of $1,043,645.40; and (d) the Company and its relevant subsidiaries, on the one hand, and the former officer and relevant entities affiliated with the former officer, on the other hand, exchanged customary mutual releases of any prior obligations among them. On May 19, 2022, the closing price for the Company’s common stock was $0.25 per share. In the fiscal quarter ending June 30, 2022, the Company measured and recognized the repurchase of its common stock at its fair value of $652,278.40, derecognized its remaining liability under the Co-Founder’s Agreement, and recognized a recovery of $324,228 in connection with the previously recognized loss related to the Co-Founder’s Agreement.

 

33
 

 

Reorganization of Korean Operations - In May 2022, the Company implemented its plan to reorganize its Korean operations. The reorganization resulted in a significant reduction in the size of the space subleased from HWH World (see Note 15 – “RELATED PARTY TRANSACTIONS” above) and a reduction (by ten) in the number of staff employed in our Korean operations. The reorganization did not result in material costs and expenses.

 

Funding Agreement With MojiLife - In May 2022, the Company and MojiLife entered into a Funding Agreement (the “Funding Agreement”) pursuant to which the Company agreed to provide to MojiLife loans up to a maximum outstanding at any point in time of $150,000, under a revolving line of credit. Borrowings under the revolving line of credit bear interest at the annual rate of 8% and cash advance granted are due and payable 180 days after each advance. Upon completion of the Funding Agreement, the Company advanced $40,000 to MojiLife.

 

NOTE 21 – SUPPLEMENTARY FINANCIAL INFORMATION

 

We are a Smaller Reporting Company, as defined in Rule 12b-2 of the Exchange Act, and, accordingly, are not required to provide the supplementary financial information otherwise required by Item 302, as amended.

 

34
 

 

PART IV

 

ITEM 15. EXHIBIT AND FINANCIAL STATEMENT SCHEDULES

 

Documents filed as part of this Annual Report:

 

(a) List of Financial Statements and Financial Statement Schedules required by Item 8 of this Annual Report: See Consolidated Financial Statements beginning on Page 1 of this Annual Report. Certain financial statement schedules have been omitted because the required information does not apply or is contained in the registrant’s Consolidated Financial Statements, including the notes thereto.

 

(b) Exhibits

 

The following exhibits are filed as part of this Annual Report or are incorporated herein by reference:

 

3.1   Second Amended and Restated Articles of Incorporation of Sharing Services Global Corporation, which is incorporated herein by reference from Exhibit A to the Company’s Proxy Statement on Schedule 14A filed on July 14, 2021
     
3.2   Bylaws of Sharing Services Global Corporation, which is incorporated herein by reference from Exhibit 3.2 to the Company’s Current Report on Form 8-K filed on January 24, 2019
     
4.1   Certificate of Designation of Series A Preferred Stock, which is incorporated herein by reference from Exhibit 3.1.2 to the Company’s Current Report on Form 8-K filed on May 8, 2017
     
4.2   Certificate of Designation of Series C Preferred Stock, which is incorporated herein by reference from Exhibit 3.1.4 to the Company’s Current Report on Form 8-K filed on May 8, 2017
     
4.3   Convertible Promissory Note dated April 13, 2018 issued by Sharing Service, Inc. in favor of RB Capital Partners, Inc., which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on April 19, 2018
     
4.4   Convertible Promissory Note dated April 5, 2021 issued by Sharing Service Global Corporation in favor of Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 1.2 to the Company’s Current Report on Form 8-K filed on April 9, 2021
     
4.5   Warrant to Purchase Shares of Sharing Services Global Corporation’s Class A Common Stock, which is incorporated herein by reference from Exhibit 1.3 to the Company’s Current Report on Form 8-K filed on April 9, 2021
     
4.6   Warrant to Purchase Shares of Sharing Services Global Corporation’s Class A Common Stock, which is incorporated herein by reference from Exhibit 10.2 to the Company’s Current Report on Form 8-K filed on December 29, 2021
     
4.7   Warrant to Purchase Shares of Sharing Services Global Corporation’s Class A Common Stock, which is incorporated herein by reference from Exhibit 4.1 to the Company’s Current Report on Form 8-K filed on January 27, 2022
     
4.8   Form of Convertible Promissory Note issued, in June 2022, by Sharing Service Global Corporation in favor of Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 4.8 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
4.9   Form of Warrant to Purchase Shares of Sharing Services Global Corporation’s Class A Common Stock issued, in June 2022, by Sharing Service Global Corporation to Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 4.9 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
10.1   U. S. Small Business Administration Note dated May 13, 2020 issued by Sharing Services Global Corporation in favor of Prosperity Bank, which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on May 18, 2020
     
10.2   Stock Purchase and Share Subscription Agreement dated as of July 22, 2020 by and between Sharing Services Global Corporation and Heng Fai Ambrose Chan, which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on July 24, 2020
     
10.3   Settlement Accommodation Agreement [Including Stock Disposition and Release Provisions] dated July 22, 2020 by and between Sharing Services Global Corporation, Bear Bull Market Dividends, Inc., Kenyatto Montez Jones, and MLM Mafia, Inc., which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on July 30, 2020
     
10.4   Securities Purchase Agreement dated as of April 5, 2021 by and among Sharing Service Global Corporation and Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on April 9, 2021

 

35
 

 

10.5   Stock Purchase and Share Subscription Agreement dated as of December 23, 2021 by and among Sharing Service Global Corporation and Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 10.1 to the Company’s Current Report on Form 8-K filed on December 29, 2021
     
10.6   Business Consulting Agreement dated January 24, 2022 by and between Sharing Service Global Corporation and DSS, Inc., which is incorporated herein by reference from Exhibit 1.1 to the Company’s Current Report on Form 8-K filed on January 27, 2022
     
10.7   Form of Distributor Agreement of The Happy Co., which is incorporated herein by reference from Exhibit 10.8 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed on June 10, 2021
     
10.8   2021 The Happy Co. Brand Partner Compensation Plan, which is incorporated herein by reference from Exhibit 10.9 to the Company’s Annual Report on Form 10-K for the fiscal year ended March 31, 2021, filed on June 10, 2021
     
10.9   Form of Securities Purchase Agreement entered into, in June 2022, by and among Sharing Services Global Corporation, and the Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 10.9 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
10.10   Form of Security Agreement made, in June 2022, by Sharing Service Global Corporation in favor of Decentralized Sharing Systems, Inc., which is incorporated herein by reference from Exhibit 10.10 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
 10.11   Form of Loan Agreement entered into, in June 2022,by and between LINDEN REAL ESTATE HOLDINGS, LLC and AMERICAN PACIFIC BANCORP, INC., which is incorporated herein by reference from Exhibit 10.11 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
10.12   Form of DEED OF TRUST, ASSIGNMENT OF LEASES AND RENTS, SECURITY AGREEMENT AND FINANCING STATEMENT made, in June 2022, by LINDEN REAL ESTATE HOLDINGS, LLC in favor of Cottonwood Title Insurance Agency, Inc., for the benefit of American Pacific Bancorp, Inc., which is incorporated herein by reference from Exhibit 10.12 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
10.13   Form of Demand Promissory Note issued, in June 2022, by LINDEN REAL ESTATE HOLDINGS, LLC in favor of AMERICAN PACIFIC BANCORP, INC., which is incorporated herein by reference from Exhibit 10.13 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
21.1   List of Subsidiaries of Sharing Services Global Corporation, which is incorporated herein by reference from Exhibit 21.1 to the Company’s Annual Report on Form 10-K filed on June 21, 2022
     
23.1   Consent of Independent Registered Public Accounting Firm *
     
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 *
     
32.1   Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
     
32.2   Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 *
     
101   The following financial information from our Annual Report on Form 10-K for the fiscal year ended March 31, 2022, and 2021, formatted in XBRL (Extensible Business Reporting Language): (i) the Consolidated Balance Sheets; (ii) the Consolidated Statements of Operations and Comprehensive loss; (iii) the Consolidated Statements of Cash Flows and (iv) Consolidated Statements of Changes in Stockholders’ Equity, which is included herein

 

*Included herewith

 

c) (Financial Statement Schedules – Not applicable

 

36
 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, on the 7th day of July 2022.

 

  SHARING SERVICES GLOBAL CORPORATION
  (Registrant)
     
  By: /s/ John Thatch
    John Thatch
    Chief Executive Officer and Vice Chairman of the Board of Directors (Principal Executive Officer)
     
  By: /s/ Anthony S. Chan
    Anthony S. Chan
    Chief Financial Officer (Principal Financial Officer)
     
  By: /s/ Everett C. Schaefer Jr.
    Everett C. Schaefer Jr.
    Principal Accounting Officer

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

Signature   Title   Date
/s/ John Thatch   Chief Executive Officer and Vice Chairman of the Board of Directors (Principal Executive Officer)   July 7, 2022
John Thatch        
         
/s/ Heng Fai Ambrose Chan   Executive Chairman of the Board of Directors   July 7, 2022
Heng Fai Ambrose Chan        
         
/s/ David K. Keene   Director   July 7, 2022
David K. Keene        
         
/s/ Frank D. Heuszel   Director   July 7, 2022
Frank D. Heuszel        
         
/s/ Castel B. Hibbert   Director   July 7, 2022
Castel B. Hibbert        
         
/s/ Robert H. Trapp   Director   July 7, 2022
Robert H. Trapp        
         
/s/ Christian Zimmerman   Director   July 7, 2022
Christian Zimmerman        

 

37